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Abstract  
Background: Among patients with multiple chronic conditions, care coordination and 
integration remains one of the major challenges facing the U.S. health care system. A 
home-based, patient-centered primary care program has been offered through the 
Veterans Health Administration (VHA) since the 1970s for frail veterans who have 
difficulty accessing VHA clinics.  The VHA Home Based Primary Care (VHA HBPC) 
aims to integrate primary care, rehabilitation, disease management, palliative care, and 
coordination of care for frail individuals with complex, chronic diseases within their 
homes.  Early research suggested that VHA HBPC was associated with positive 
outcomes (e.g., reduced resource use and patient satisfaction).  However, evidence 
regarding the effect of the VHA HBPC program on health services use (especially 
hospital and nursing home use), expenditures, and other patient outcomes remains 
limited.  The present study is designed to fill this gap as the rise in the number of 
veterans with complex health care needs will likely increase in the coming decades.   
Objectives:  The current study aimed to examine the impact of VHA HBPC on health 
services use, expenditures, and mortality among a cohort of new VHA HBPC enrollees 
identified in the national VHA data system.  The specific aims of this study were: 1) to 
examine the effect of VHA HBPC on major health service use (hospital, nursing home, 
and outpatient care) paid for by the Veterans Administration; 2) to examine the effect of 
VHA HBPC on total health services expenditures; and 3) to examine whether VHA 
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HBPC enrollees experienced similar mortality and survival as compared to a matched 
concurrent cohort.  
Methods: This study used a retrospective cohort design. A new VHA HBPC enrollee 
cohort (the treatment group) and a propensity matched comparison cohort (the 
comparison group) were identified from VHA claims in fiscal years (FY) 2009 and 2010 
and were followed through FY 2012. Data on health service use, expenditures, and 
mortality/survival data were obtained via the VHA administrative datasets (i.e., Decision 
Support System, Purchased Care, and Vital Status Files). Propensity scores of being 
enrolled in the VHA HBPC were generated by a logistic regression model controlling for 
potential confounders.  After 41,244 matched pairs were determined adequate through 
several diagnostic methods, means tests, relative risk analyses, and generalized linear 
models were used to estimate the effect of VHA HBPC on outcomes.  Additionally, a 
Cox proportional hazards regression model was used to estimate the effect of VHA 
HBPC on survival. Subgroup analyses were conducted stratifying by age (85 and older), 
comorbidities (2 or more), and the receipt of palliative care.  Based on the results of the 
original analyses, a series of sensitivity analyses were conducted that modified the 
described sample selection criteria and matching algorithm. 
Results: Analyses of the original cohort revealed that VHA HBPC patients had 
significantly higher risks of being admitted into a hospital (RR 1.53, 95% CI 1.51-1.56) 
or nursing home (RR 1.65, CI 1.50 - 1.81).  The average total expenditures during the 
study period were significantly higher for the VHA HBPC group as compared to the 
control group ($85,808 vs. $44,833, respectively; p < .001). In terms of mortality and 
survival, VHA HBPC enrollees had higher mortality (RR 1.45, CI 1.43 – 1.47), and 
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shorter survival (HR 1.89, CI 1.86 – 1.93) as compared to those in the comparison 
group. Subgroup analyses found that these relationships generally remained when 
stratified by age 85 or older or having two or more comorbidities.  However, for those 
who received palliative care, VHA HBPC participants had significantly lower risk of VHA 
hospitalization overall (RR 0.84, CI 0.81 – 0.87) and immediately prior to death. Finally, 
exploratory post-hoc analysis suggested that VHA HBPC recipients were at higher risk 
of VHA hospitalization at 30 (RR 1.11, CI 1.06 – 1.16), 60 (RR 1.16, CI 1.11 – 1.20), 
and 90 days (RR 1.16, 1.12 – 1.21) prior to death relative to the comparison group.  
After selecting only those that had a baseline hospitalization and refining the matching 
algorithm to account for time to death and additional comorbidities, VHA HBPC 
participants who had been enrolled in the program for at least six months had lower 
risks for hospital (RR 0.89, CI 0.88 – 0.90) and nursing home admissions (RR 0.74, CI 
0.67 – 0.81).  However, total expenditures remained significantly higher among those in 
VHA HBPC relative to the comparison group ($89,761 vs. $85,371, respectively; p 
< .001). 
Discussion:  This study found that without accounting for important covariates such as 
initial hospitalization, time to death, and a range of comorbidities, VHA HBPC was 
associated with higher health service use, higher expenditures, higher mortality, and 
shorter survival as compared to a similar group of patients not receiving VHA HBPC.  
After accounting for these factors, VHA HBPC was associated with a lower risk of 
nursing home use, and after six months, VHA HBPC was associated with lower risk of 
both nursing home and hospital use.  These findings suggest that while VHA HBPC 
may improve quality of life and patient satisfaction through patient-centered integrated 
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primary care, it may not generate cost savings for the healthcare system. Future 
research is needed to understand variation in program implementation and how this 
affects the impact of VHA HBPC on service use and cost.   
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Chapter 1: Background 
 
Introduction 
The importance of primary care is underscored by the Agency for Healthcare 
Research and Quality’s notion of primary care being “foundational” to achieving a better 
healthcare system (Agency for Healthcare Research and Quality, 2013b).  Primary care 
physicians are the most common type of physician utilized for a single condition or for 
multiple conditions among patients with all degrees of comorbidity (Centers for Disease 
Control and Prevention, 2010; Starfiled et al., 2003).  Even when patients have a high 
degree of comorbidity, patients are still more likely to see their primary care physician 
compared to a specialist (Centers for Disease Control and Prevention, 2010; Starfiled et 
al., 2003).   
Patients with comorbidities are prevalent among primary care practices.  Among 
a sample of 226 primary care practices across 43 states, it was determined that 45.2% 
of patients had more than one comorbidity and that comorbidity increases with age 
(Ornstein, Nietert, Jenkins, & Litvin, 2013).  Focusing on the nature of primary care 
practice and the prevalence of comorbidity, Starfield et al. (2003) posited that primary 
care should retain its stronghold as the basis for patient care but should also consider 
evolving to adequately address patient needs.  One of these evolutions in healthcare 
has been the rise of the medical home. 
Though not a new term, the concept of the medical home has gained in 
popularity, as part of a growing effort to provide complex patients with more 
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comprehensive care.  The patient-centered medical home is characterized as care that 
is continuous, comprehensive, accessible, and coordinated across providers 
(Rittenhouse & Shortell, 2009).  Additionally, the medical home is one that is team-
based according to the patients’ needs and can include an array of providers (e.g., 
specialists, nurses, social workers, pharmacists, therapists).  Medical homes, in 
particular, have been associated with lower total costs and outpatient costs among the 
most costly and complex patients (Flottemesch et al., 2012) and are conceptualized 
based on the components of evidence-based medicine and an ongoing partnership 
between patients and physicians (American College of Physicians, 2005).   
To continue efforts to improve healthcare in general, and in primary care 
specifically, the American College of Physicians promotes the delivery of care through 
the medical home based on the Chronic Care Model recognizing the complexity and 
chronicity of patients and their conditions and posit that this model of care can be 
applicable to those with or without chronic conditions (American College of Physicians, 
2005). This model of care delivery emphasizes the relationship between the patient and 
the physician and care self-management guided by decision support tools that includes 
a range of options supporting the patient’s health goals (American College of Physicians, 
2005).   
Chronic disease management is important to controlling healthcare costs, 
especially considering that those with multiple chronic conditions cost up to seven times 
as much as those with only one condition (Agency for Healthcare Research and Quality, 
2006) and a substantial portion of the rise in costs among Medicare beneficiaries over 
the last two decades has been attributed to the management and treatment of chronic 
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conditions such as diabetes and hypertension (Thorpe, Ogden, & Galactionova, 2010).  
Chronic disease management and treatment was associated with 75% of the $2 trillion 
spent on healthcare in the U.S. (Centers for Disease Control and Prevention, 2009, 
2013).  In 2010, Medicare spent over $300 billion on beneficiaries, and among those 
with six or more chronic conditions, the cost was three times as much as the average 
Medicare beneficiary (Centers for Medicare & Medicaid Services, 2012).  Furthermore, 
the Veterans Administration’s (VA) expenditures for chronic diseases were $14.3 billion 
over ten years ago (Yu et al., 2003) and such expenses are likely considerably higher 
today.   
Not surprisingly then, many models of care aim to both enhance patient quality of 
care and safety, as well as reduce unnecessary expenses, hospitalizations, adverse 
events, and disease exacerbation by providing enhanced care continuity.  This is 
important because each time there is a change in care, there is an opportunity for 
miscommunication where information about patient preferences and goals can be 
jeopardized (Coleman, 2003; Hauser, 2009).   
Moreover, those individuals that are among the frailest of patients likely have 
difficulty accessing healthcare.  Access issues span a range of challenges including 
social, societal, and behavioral, but fundamentally, decreased access to primary care is 
associated with adverse outcomes, for example, higher mortality (Jerant, Fenton, & 
Franks, 2012). 
Home-based primary care can be a solution for those who cannot receive care in 
a traditional clinical setting and has been characterized as an “emerging model of 
primary care” (Landers et al., 2005).  Given the importance of chronic disease 
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management, those who cannot access healthcare due to being homebound are a 
group of highly vulnerable patients. There are an estimated 3.6 million older adults who 
are considered homebound (Qiu et al., 2010). 
Specifically, the homebound have higher rates of metabolic, cardiovascular, 
musculoskeletal conditions, and higher rates of cognitive impairment, dementia, and 
depression (Qiu et al., 2010).   In a study of chronically ill homebound individuals, it was 
found that 49% had dementia, 33% had diabetes mellitus, 26% had depression, 18% 
had coronary heart disease, and 13% had cancer (Wajnberg, Ornstein, Zhang, Smith, & 
Soriano, 2013).  Moreover, the same study found that the most common symptoms 
among the homebound were loss of appetite, lack of well-being, tiredness, and pain 
(Wajnberg et al., 2013).   
In the broader healthcare context, primary care provided in patients’ homes has 
the potential to effectively fill a gap in services for homebound individuals (Desai, Smith, 
& Boal, 2008).  Primary care delivered in patients’ homes is delivered mostly by 
geriatricians and family or internal medical doctors in order to improve patient care and 
autonomy (Landers, Gunn, & Stange, 2009).  However, the effectiveness of this model 
to improve patient outcomes is mixed, and overall, there seems to be limited evidence 
on home-based primary care provided in the U.S.  Others have suggested that in order 
to expand home-based primary care as a delivery model, more rigorous research on 
home-based primary care is needed (Olsan, Shore, & Coleman, 2009).   
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Therefore, the current study examines the VHA’s Home Based Primary Care 
(VHA HBPC)1 by determining the effectiveness of the program on service use, cost, and 
survival.  First, a review of the literature on home-based primary care (in general, not 
limited to the VHA HBPC program) in the United States is presented. It should be noted 
that the literature focused specifically on primary care delivered in the home is limited.  
Therefore, this review includes literature on house calls made by physicians specifically 
for primary care and includes literature referring to physician house calls that did not 
specify primary care, but identified physician’s specialties as geriatricians, family 
physicians, general practitioners, or internal medical doctors delivering routine care in 
patient’s homes. Following the review, an overview of VHA HBPC is provided including 
a review of the evidence.  Then, the present study is described, followed by a 
discussion of the implications of the results. 
 
Physician Services Provided In Patients’ Homes 
Prevalence of Home-Based Primary Care & Physician House Calls. Overall, 
very few (<1%) older adults receive a house call from a physician (Landers et al., 2005; 
Meyer & Gibbons, 1997).  However, there seems to be a re-emergence of such care.  
From 1998 to 2004, the annual number of Medicare beneficiaries who received house 
calls increased by 43% (Landers et al., 2005).  While this is a relatively large increase, 
the overall rate of house call utilization remains low, increasing from 0.78% in 1998 to 
0.90% of all out-patient evaluation and management services among fee-for-service 
Medicare beneficiaries (Landers et al., 2005).  Similarly, Peterson, Landers, & 
                                                           
1 The acronym for the Home Based Primary Care, VHA HBPC, is used only when referring to the program 
provided through the Veteran’s Health Administration (VHA).  When home-based primary care is spelled 
out, it is referencing this type of care in general terms, i.e., not specific to the VHA. 
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Bazemore (2012) found that the number of physician house calls more than doubled 
from 478,000 in 2000 to 995,294 in 2006 among Medicare beneficiaries, coinciding with 
an increase in the number of beneficiaries who received house calls (up from 164,825 in 
2000 to 282,526 in 2006).  However, the number of physicians making house calls 
declined, indicating that a smaller number of physicians were seeing a higher volume of 
patients in their homes (Peterson et al., 2012).   Of note, visits by nurse practitioners 
and physicians assistants to patients in the home increased between 1998 to 2004 
(Landers et al., 2005).    
Using the 2004 National Long Term Care Survey, Liang & Landers (2008) found 
that 4% of the sample, or 168 out of 4,953 respondents, reported receiving a house call 
from a physician.  This rate of receiving a physician house call is high in comparison to 
other evidence.  Part of the discrepancy in the rate of physician house calls could be 
due to the definition of a physician house call and due to the differences between self-
reported and claims data.   
Recipients of Home-Based Primary Care & Physician House Calls. Those 
who receive house calls are often more frail with more functional limitations compared 
to those that do not receive this service (Liang & Landers, 2008).  Specifically, those 
who utilized a physician in the home compared to those that did not utilize a physician in 
the home were more often: older (84 years of age versus 81), non-white (17% 
compared to 10%), a recipient of Medicaid (23% versus 16%), living in an urban area 
(29% compared to 18%), residing in housing that had support for older adults or adults 
with disabilities (24% versus 16%), had 2 deficits in activities of daily living (ADLs; 
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compared to 1), had 3 deficits in instrumental ADLs (IADLs; compared to 1), and were 
more often hospitalized in the last year (37% compared to 28%; Liang & Landers, 2008). 
Similarly, in a review of the literature from 1990 to 2006, home-based primary 
care models were described as serving those that: are frail, are in need of assistance 
with 3 or more ADLs, have IADL dependencies, and, often serve those with a range of 
mobility including those that can leave their homes for short durations to those that are 
strictly homebound (Olsan et al., 2009).   Additionally, these programs typically serve 
those that are white, widowed females, age 65 years and older who often have low, 
fixed incomes (Olsan et al., 2009).  The chronic conditions of those served by these 
programs are typical of older adults in general and include: hypertension, heart disease, 
congestive heart failure, chronic obstructive pulmonary disease, stroke, diabetes, 
depression, dementia, osteoarthritis, cancer, infections, impaired vision and hearing, 
falls, pressure ulcers, and malnutrition (Olsan et al., 2009).   
A well-established home-based primary care program, St. Vincent’s Hospital’s 
Chelsea-Village Program (Kellogg & Brickner, 2000), has served older, frail residents of 
New York City since the 1970’s by providing longitudinal, multidisciplinary care in 
patients’ homes.  The care team is comprised of physicians, resident physicians, nurses, 
and social workers.  The average patient is 84 years old and is characterized by 
common ailments of old age such as, pulmonary and cardiac issues, orthopedic needs, 
neurologic disorders, and generalized weakness and frailty (Kellogg & Brickner, 2000).   
The program is now known as the Mount Sinai Chelsea-Village House Call Program or 
the Mount Sinai Visiting Doctors Program and provides care to the underserved 
homebound population (Mount Sinai Hospital, 2013).   
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An analysis of 27-years of data from St. Vincent’s Hospital’s Chelsea-Village 
Program described it as serving those that mostly lived alone (57.9%), considered 
themselves single (22.3%) or widowed (46.8%), and were referred to the program 
through the hospital (44.1%) or through someone in the community (49.2%; Kellogg & 
Brickner, 2000).  A more recent analysis of the program between 2008 and 2010 found 
that 75% of new enrollees were female, 36% were White, 43% had Medicaid, 38% lived 
with a caregiver, 91% needed assistance with one or more ADLs, and 99% needed 
assistance with one or more IADLs (Wajnberg et al., 2013).  
Another housecalls program was established in 1980 as part of a larger 
ambulatory practice with three geriatricians and two nurse practitioners in Providence, 
Rhode Island (Reuben, Fried, Wachtel, & Tinetti, 1998).  Between 1993 and 1995 an 
analysis of 71 outpatient medical records were reviewed and described the program as 
serving mostly females (81% of patients) aged 85 or older (52% of patients) who were 
dependent in bathing and dressing (65% and 42% of patients, respectively) and were 
treated for acute illnesses (59% of patients) including upper respiratory tract infections, 
pneumonia, and congestive heart failure (Reuben et al., 1998).  All patients lived within 
15 minutes of the medical center but none were able to leave their homes for routine 
care due to ambulatory issues, or in a few cases, psychological barriers (Reuben et al., 
1998). Patients were seen, on average, five times a year for either routine or urgent 
care (Reuben et al., 1998).  
The Effects of Home-Based Primary Care & Physician House Calls. Several 
authors have concluded that this mode of the delivering physician’s services is 
consistently associated with patient and caregiver satisfaction (Anetzberger, Stricklin, 
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Gauntner, Banozic, & Laurie, 2006; Laditka, Jenkins, Trevisani, & Mathews, 2001; 
Muramatsu, Mensah, & Cornwell, 2004; Olsan et al., 2009).  In particular, patients and 
caregivers reported a positive psychological impact from knowing they had access to in-
home medical care, and caregivers reported feeling empowered, informed, and relieved 
from the burden of transporting patients to and from medical appointments (Muramatsu 
et al., 2004).  Patients also noted that physician’s house calls provided access to care 
they otherwise would not have received (Laditka et al., 2001). 
Intended to fill a gap among the homebound, home-based primary care should 
decrease the use of other types of unnecessary or inappropriate care by providing 
enhanced access to care and care management.  To understand the effect of 
enrollment into a house calls program, Wajnberg et al. (2010) used a pre-post design to 
determine the effect of a house call program on hospitalizations and skilled nursing 
facility utilization among a sample of patients in a capitated insurance program, the 
Montefiore Medical Center Care Management Company (Wajnberg et al., 2010).  It was 
found that there was a significant decrease in the rate of hospitalization after enrollment 
(61% prior to and 38% after, p < .001) and a significant decline in the use of skilled 
nursing facilities (38% before enrollment and 18% after, p < .001; Wajnberg et al., 2010).  
The authors suggested that increased access to healthcare could explain the reason for 
the change in hospital and skilled nursing facility utilization. 
However, the evidence of the effectiveness of these services is not invariable.  A 
two-year randomized controlled trial of a collaborative model of primary care included 
primary care physicians, registered nurses, and case assistants who conducted patient 
and family assessments in the patients’ homes or clinic offices, provided home visits or 
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clinic visits, and provided coordination and supportive longitudinal care (Schraeder, 
Shelton, & Sager, 2001).  Compared to a group not receiving treatment, evaluation of 
the program did not find a reduction in the rates of hospital use among participants in 
the treatment group after the first year (26.4% of treatment group versus 21.7% of 
comparison group) or after the second year (25.0% versus 22.6%; Schraeder et al., 
2001).  There was also not a significant difference in length of hospital stay (6.0 days 
after year 1 and 5.3 after year 2 among the treatment group compared to 5.0 after year 
1 and 6.1 in year 2 among the comparison group), or Medicare payments (Schraeder et 
al., 2001).  Not surprisingly then, the cost of the program was not offset by a reduction 
in hospital use.  The authors, however, concluded that the intervention enhanced 
patient outcomes since those in the treatment group had a significantly lower risk of 
death during the second year (odds ratio = 0.51, 95% confidence interval [CI] = 0.29 - 
0.91; Schraeder et al., 2001). 
The Business Case for Home-Based Primary Care & Physician House Calls. 
In 1993, it was estimated that physician house calls cost Medicare $63.2 million, or 0.2% 
of all Medicare physician expenditures (Meyer & Gibbons, 1997).  An analysis of the St. 
Vincent’s Hospital’s Chelsea-Village Program estimated that the average cost per 
person per year of patient care was $3,936 (Kellogg & Brickner, 2000).   
The adoption of home-based primary care models has been relatively slow, likely 
due to the fact that direct billing of such services does not generate enough revenue to 
meet operating costs (Desai et al., 2008).  However, Desai et al. argued that such 
programs can generate substantial revenue at the systems level despite the inability of 
a program to generate enough revenue to operate independently (Desai et al., 2008).  
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For example, in fiscal year 2001 a local Midwestern physician’s house call program 
generated $623,987 despite the $119,879 deficit incurred to the health system in which 
the program operated (Muramatsu et al., 2004).  The author described the benefit of the 
program to the health system as being the largest referral source for the system’s home 
health agency and hospice programs (Muramatsu et al., 2004).  Another program, 
operated through Johns Hopkins Hospital System, also produced an overall shortfall of 
$84,165 in fiscal year 1992 (Finucane, Fox-Whalen, & Burton, 1994).  The authors 
noted similarly that the benefit of the program from referrals to the hospital was 
justification for the program and resources (Finucane et al., 1994). 
More recent evidence suggests that home-based primary care can be cost-
effective.  In a well-designed observational analysis of Medicare’s Independence at 
Home program, De Jonge et al. (2014) found that recipients had significantly lower 
Medicare costs compared to a matched control group.  Moreover, the effect of the 
program seemed most promising among the most frail, which tend to be generally the 
most costly group of patients. 
 
VHA HBPC 
A home-based primary care program that serves a demographically different 
population (compared to those served in the programs described above) is offered 
through the VHA to eligible patients. VHA HBPC  offers primary care, rehabilitation, 
disease management, palliative care, and coordination of care to frail individuals with 
complex, chronic diseases within their homes (Department of Veterans Affairs, 2007).  
Although primary care is a focus of the program, VHA HBPC is described as providing 
comprehensive in-home long-term care services (Department of Veterans Affairs, 2007) 
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and is operationally similar to that of the patient-centered medical home model.  Early 
research suggested that VHA HBPC (then referred to Hospital Based Home Care) 
provides a comparatively wide array of services to enrollees (Weaver et al., 1995). 
VHA HBPC began being offered through the VHA in 1970 as a demonstration 
project and was modeled after the program at the Montefiore Hospital in New York 
(Cooper, Granadillo, & Stacey, 2007).  The VHA’s program was designed to provide 
long-term in-home care for older adults that could be cared for at home but were unable 
to receive care at outpatient clinics (Cooper et al., 2007).  The program was not 
designed to be a substitute for long-term institutional care (Cooper et al., 2007).   
VHA HBPC is considered unique in that patient-centered services are provided 
through an interdisciplinary team in a longitudinal fashion usually through death rather 
than care provided only during disease exacerbation (Department of Veterans Affairs, 
2007).  This is noteworthy because the average VHA HBPC enrollee has more than 
eight chronic conditions, limitations in two or more activities of daily living, spends an 
average of 315 days in the program (Beales & Edes, 2009), and is often discharged due 
to death.  Therefore, the VHA HBPC population is a vulnerable population in which high 
medical expenses could easily be incurred.  
Like other physician house call programs, VHA HBPC aims to reduce the use of 
unnecessary services by providing access to care and chronic disease management.  
This is important since recently the Congressional Budget Office suggested that the 
future costs of VHA healthcare will be “substantially higher” than the amount 
appropriated (Congressional Budget Office, 2010).  This is due, in part, to the increased 
use of medical care provided through the VHA (Marlis, 2012).  For example, the 
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average daily number of Veterans receiving non-institutional extended care (which 
includes VHA HBPC and other programs such as adult day care, skilled nursing and 
rehabilitation, and home health) increased from 95,092 Veterans in 2011 to 113,254 
Veterans in 2012 to an estimated 120,118 Veterans in 2013 (Department of Veterans 
Affairs, 2013).   
A Program Description of VHA HBPC. VHA HBPC provides “all-inclusive” 
home care to individuals with complex, chronic diseases whose condition is likely to 
worsen over time (Department of Veterans Affairs, 2007).  This program was originally 
established in 1972 as the Hospital Based Home Care program and has since been 
renamed the Home Based Primary Care Program to better reflect the setting in which 
care is most often provided (Department of Veterans Affairs, 2007).  
 Continuous patient-centered care led by a physician-supervised interdisciplinary 
team is provided in the homes of Veterans.  Specifically, VHA HBPC enrollees are 
monitored on an ongoing basis, have routine comprehensive assessments to prevent or 
detect the worsening of a condition, and receive timely interventions throughout the 
course of their disease (Department of Veterans Affairs, 2007).  VHA HBPC provides 
care that is characterized as continuous and comprehensive rather than time-limited 
and specific such as home care services provided through other means (Department of 
Veterans Affairs, 2007).   
The services provided through VHA HBPC are meant to be accessible, 
comprehensive, coordinated, longitudinal, accountable, and acceptable (Department of 
Veterans Affairs, 2007).  Specifically, patient access to providers is available for 
emergencies during nights, weekends, and holidays.  Comprehensive services are 
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holistic in order to treat the majority of the enrollee’s health problems.  Coordinated care 
provided by VHA HBPC is defined as providing patient referrals to appropriate services, 
collaboration and communication to the primary care providers and specialists, and 
education about disease treatment and self-care for the patient and caregiver.  
Accountable care is described as attention to resource management and providing cost 
efficient care.  Acceptable care refers to the consent of the patient and caregiver of VHA 
HBPC and the willingness to participate in the goals of the individualized care plan 
(Department of Veterans Affairs, 2007). 
The goals of the program are to promote the Veteran’s health and independence, 
reduce the need for hospitalization or other institutional care, assist in transitioning the 
Veteran from a health care facility to home, provide support to the caregiver, enhance 
the Veteran’s quality of life through symptom management, provide assistance with 
chronic disease management, meet the changing healthcare needs of the Veteran, and 
provide the option of dying at home (Beales & Edes, 2009).  With an interdisciplinary 
team monitoring care, greater coordination of services designed to result in an 
enhanced level of care continuity.  In fact, VHA HBPC incorporates specific features 
that have been associated with improved care and reduction in need for hospitalization 
among high-risk patients such as frequent in-person contact, acting as a 
communications hub, delivering evidence-based education to patients, and providing 
timely and comprehensive transitional care after hospitalizations (Brown, Peikes, 
Peterson, Schore, & Razafindrakoto, 2012).   
The target population of VHA HBPC is Veterans who do not benefit from clinic-
based services due to their inability to access services, usually due to their illness or 
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disability.  Specifically, VHA HBPC targets: those with impaired mobility or functional 
limitations which make leaving the home difficult without assistance of another individual; 
those who are unable to cope with the clinical environment due cognitive, physical or 
psychiatric impairment; those who need frequent, coordinated interventions from 
multiple episodes; those who require hospice care for an advanced disease; and those 
who experience recurrent hospitalizations or urgent care episodes or are at risk of 
nursing home placement and have either congestive heart failure, chronic obstructive 
pulmonary disease, a neurological disease, diabetes mellitus, coronary artery disease, 
cancer, acquired immunodeficiency syndrome, and/or end-stage liver disease 
(Department of Veterans Affairs, 2007).   
A description of VHA HBPC enrollees suggests that the average age of enrollees 
is 76.7 years, with an average of 19.36 diagnoses that require continuous management, 
and take an average of 15 medications per enrollee (Cooper et al., 2007).  Furthermore, 
many VHA HBPC enrollees are being treated for depression and most have some form 
of cognitive impairment (Cooper et al., 2007).   
In addition to the targeting criteria, admission requirements for the program 
include: living within the VHA HBPC service area; the Veteran and/or caregiver 
accepting VHA HBPC as the primary care provider; the determination that the Veteran’s 
needs can be met by VHA HBPC; the Veteran has an identified caregiver if determined 
necessary by the VHA HBPC team; the home has been determined the most 
appropriate place for care as determined by the VHA HBPC team; and the home 
environment has been deemed safe for the well-being of the Veteran, caregiver, and 
VHA HBPC team (Department of Veterans Affairs, 2007). 
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Once enrolled, many Veterans are served by VHA HBPC for the remainder of 
their lives.  Discharge from VHA HBPC can be for the following reasons: death, 
inpatient stay for 16 or more days, a determination that the Veteran can be effectively 
treated through routine clinic-based care, the needs of the Veteran exceed the 
capabilities of the VHA HBPC team, the Veteran or caregiver request discharge from 
the program, the Veteran and/or caregiver do not participate adequately in the treatment 
plan, the home environment is considered unsafe for either the Veteran and/or the VHA 
HBPC team members, continuation of home care is determined to be unsafe for the 
Veteran or caregiver relative to other care options, or the Veteran relocates out of the 
service area.  If a VHA HBPC enrollee is discharged from the program due to an 
inpatient stay of 16 or more days but later is readmitted to VHA HBPC, the complete 
interdisciplinary assessment (described below) must be repeated and the Veteran is 
treated as new patient. 
Services provided in VHA HBPC include primary care, rehabilitation, disease 
management, palliative care, and coordination of care.  An interdisciplinary team is in 
place to provide the necessary services and includes a physician medical director, a 
program director, and staff from nursing, social work, rehabilitation, dietetics, and 
pharmacy.  Other services often needed include pastoral and mental health services.  
Every VHA HBPC program has a minimum of 3 full time, direct care nursing staff 
members, but the specific staffing mix is specified such that the VHA HBPC team must 
be able to meet the needs of the patient population (Department of Veterans Affairs, 
2007).   
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Case loads are determined at the local level and usually range between 20 to 30 
patients to each registered nurse or licensed practical nurse, 80 to 105 per social 
worker, 85 to 155 per rehabilitation therapist, and 95 to 125 per dietician (Department of 
Veterans Affairs, 2007). Teams meet weekly to discuss patients and determine care 
plans.  The frequency of home visits are based on the Veteran’s needs and clinical 
judgment (Department of Veterans Affairs, 2007). 
 Veterans can be referred to VHA HBPC from any care setting as long as the 
primary care provider concurs with VHA HBPC being an appropriate mode of care for 
the Veteran.  Once referred, the Veteran must be evaluated by at least one member of 
the VHA HBPC program to determine if the home environment is appropriate for VHA 
HBPC.  Once this determination is made, the Veteran is assessed in their home by at 
least three team members specializing in different disciplines.  Assessment includes 
health history, physical, psychosocial, financial, cultural, spiritual, nutritional, functional, 
home environment, and pain symptomology.  The members of VHA HBPC formulate 
individualized treatment plans based on the Veteran’s and caregiver’s needs.  If 
services are received outside of the VHA HBPC team, VHA HBPC adopts a medical 
management and care coordination role. The treatment plan is modified as needed and 
reviewed at least every 90 days (Department of Veterans Affairs, 2007). 
 VHA HBPC collaborates with services that cannot be provided through the direct 
care staff of the VHA HBPC team.  These services can include mental health services, 
short-term respite, personal care, skilled home care that is beyond the scope or 
frequency of VHA HBPC, palliative care, care coordination, home telehealth to expand 
the geographical reach of the program, volunteer services, and other VHA services that 
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enable appropriate management of VHA HBPC patients (Department of Veterans 
Affairs, 2007).  These ancillary services can be provided through VHA or through 
Medicare if the Veteran is enrolled in Medicare.  The Veteran has the ultimate right to 
choose where to receive services but the VHA must offer to pay for contracted care or 
provide the necessary services (Department of Veterans Affairs, 2005, 2007, 2008). 
Evidence on VHA HBPC.  Several studies have examined the VHA HBPC 
program including both descriptive and quantitative analyses.  Below is an overview of 
these studies, followed by a discussion of the limitations and remaining questions 
regarding VHA HBPC. 
Patient outcomes associated with VHA HBPC. An early randomized study of 
VHA HBPC among those with severe disabilities or who were terminally ill was 
conducted utilizing data from 1984 through 1987 from the Hines, Illinois VHA hospital.  
Survival was similar in both VHA HBPC patients (124.6 days) and the control group 
(128.2 days) (Cummings et al., 1990).  To determine differences in patient outcomes, 
multivariate analysis of covariance indicated that there were no differences between the 
groups in terms of ADL functioning, cognition, or patient morale at one or six months 
following baseline (Cummings et al., 1990).  However, differences were found at one 
but not six months after baseline for patient satisfaction with VHA HBPC recipients 
reporting significantly higher levels of satisfaction with care compared to controls 
(Cummings et al., 1990). 
Another early analysis of the Hines, Illinois VHA hospital’s HBPC program 
indicated that there were no differences between the terminally ill enrolled in VHA 
HBPC compared to a randomized comparison group in terms of ADL limitations, 
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cognitive status, or morale at one month from baseline but found that VHA HBPC 
enrollees had higher patient satisfaction at one month (p = .02), although this difference 
was not maintained through the six month evaluation (Hughes et al., 1992).  This study 
also examined survival days and found that VHA HBPC recipients were not different 
than the control group (76.2 days vs. 83.1 days) (Hughes et al., 1992).  However, 
survival time revealed a marked difference (i.e., shorter duration) from the earlier 
examination of survival time among terminally ill patients at the same VHA medical 
center (Cummings et al., 1990). 
A later and larger study of 16 VHA HBPC programs found that patients with a 
terminal diagnosis who were enrolled in VHA HBPC had significant improvement in 
health-related quality of life compared to those in the control group (Hughes et al., 2000).  
However, there was no difference in health-related quality of life between groups among 
the non-terminally ill (Hughes et al., 2000).  Among terminal patients, there was no 
difference found in patient satisfaction among those enrolled in VHA HBPC compared to 
terminal patients not in VHA HBPC (Hughes et al., 2000).  There was, however, a 
significant increase in patient satisfaction among nonterminal patients in VHA HBPC 
(Hughes et al., 2000).  Similar to these earlier studies, a recent study interviewed 31 
newly enrolled VHA HBPC recipients who reported high levels of satisfaction with VHA 
HBPC team access, education, and continuity of care (Edes et al., 2014). 
Service use associated with VHA HBPC.  Cummings et al. (1990) found that 
those receiving VHA HBPC were more likely to receive visits from a physician, physical 
therapist, social worker, and home health aide and/or dietician compared to a 
randomized control group receiving usual care even despite both groups receiving 
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similar number of service visits on average (22.8 for VHA HBPC enrollees compared to 
21.7 for controls).  The number of days receiving of home care was significantly greater 
for those in VHA HBPC compared to the control group (98 vs. 79 days, respectively) 
(Cummings et al., 1990).  Number of days spent in a VHA hospital did not differ 
significantly by group although there was a difference in time in specific hospital wards.  
VHA HBPC recipients spent a higher proportion of their time on the intermediate care 
ward and less time on the general care wards compared to the control group 
(Cummings et al., 1990).  Outpatient service utilization differed significantly with VHA 
HBPC recipients receiving fewer outpatient clinic visits (1.33 visits compared to controls 
3.39 visits) (Cummings et al., 1990).  The authors concluded that the program was not 
associated with adverse outcomes and resulted in marginal reductions in hospital length 
of stay. 
In another analysis, the Hines VHA study of the terminally ill in VHA HBPC, found 
that there was a significant decline in number of hospital days, from an average of 15.9 
days prior to enrollment to an average of 10 days and VHA HBPC enrollees spent an 
average of 3.5 fewer days in the hospital immediately prior to death compared to the 
randomized control group receiving usual care (Hughes et al., 1992).  There were also 
differences in the number of outpatient clinic visits by group with VHA HBPC patients 
having significantly fewer outpatient visits although VHA HBPC recipients had 
significantly more home visits from a nurse compared to controls  (Hughes et al., 1992).   
A larger study of 16 VHA HBPC programs by Hughes et al. (2000) found a 
relative reduction in the proportion of VHA HBPC enrollees who were admitted to the 
hospital in the first six months, but the reduction was not retained at 12 months.  
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Additionally, a relative reduction in hospital readmissions was found only at six months 
among those enrolled in VHA HBPC (Hughes et al., 2000).  There was also not a 
significant difference in the number of hospital days among re-hospitalizations between 
the VHA HBPC and control groups (Hughes et al., 2000).  
Chang, Jackson, Bullman, and Cobbs (2009) assessed 183 VHA HBPC 
enrollees from the Washington, DC program who were in the program for at least six 
months during 2001 to 2002 and found that there was a significant decrease in the total 
number of hospitalizations (-43.7% change) and the total number of days in the hospital 
(-49.9% change) after enrolling into the program compared to prior to enrollment.  
However, they did not find a significant difference in the total number of emergency 
department visits (-18.5% change, non-significant) after enrollment into VHA HBPC 
(Chang et al., 2009).   
In an analysis of a Missouri VHA HBPC program that specifically targeted those 
in advanced stages of chronic heart failure and chronic obstructive pulmonary disease, 
it was determined through linear regression that actual hospitalization days were 7.5 
days per patient per six months less than expected (p < .001) (Edes, Lindbloom, Deal, & 
Madsen, 2006).  
Cost associated with VHA HBPC.  A cost analysis was conducted on the 
Missouri VHA HBPC program that targeted those in advanced stages of chronic heart 
failure and chronic obstructive pulmonary disease.  It was found that those enrolled in 
VHA HBPC produced a cost savings of $1,873 per patient per month based on reduced 
services use including a reduction in hospital days after enrollment in the program 
compared to pre-enrollment (Edes et al., 2006).  This was based on the difference of 
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the cost of services prior to enrollment versus during enrollment by calculating the sum 
of the median number of hospital days (decrease from 7.5 to 1), median ancillary 
outpatient visits (decrease from 10 to 7), median allied health outpatient visits (3, no 
change), primary and specialty care visits (decrease from 9 to 6), and the VHA HBPC 
visits (increase from 0 to 6).  Similarly, another more recent analysis was conducted 
comparing expected costs to actual costs for 9,425 newly enrolled VHA HBPC 
recipients which found that Medicare costs were 10.8% lower than projected, VA plus 
Medicare costs were 11.7% lower than expected, and combined hospitalizations were 
25.5% lower than prior to VHA HBPC enrollment (Edes et al., 2014). 
These findings supported the early randomized cost effectiveness study that 
determined that VHA HBPC produced a net savings of 13% compared to those in usual 
care (Cummings et al., 1990) and another study that suggested that VHA HBPC 
produced a net savings of 18% (albeit non-significant difference) among those 
diagnosed with a terminal condition with a 6-month prognosis (Hughes et al., 1992). 
Although those in VHA HBPC had significantly more home health care than the 
comparison group which more than doubled the cost of home care ($658 more in 1985 
dollars), the savings were attributed to lower VHA (48% lower) and private sector 
hospital costs over a six month period and to lower institutional care costs for those 
enrolled in VHA HBPC (Hughes et al., 1992).  Based on the differences in rates of 
utilization, these findings on cost differences were expected. 
Another cost analysis finds different results than the four aforementioned studies.  
The analysis of 16 VHA HBPC programs found that total costs among those enrolled in 
VHA HBPC were 6.8% higher compared to the randomized control group.  Even though 
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the costs among the VHA HBPC group were lower for hospital readmissions and private 
sector costs, home-based care and nursing home costs were significantly higher 
compared to the control group (Hughes et al., 2000).  The only sector identified as 
significantly reducing cost among the VHA HBPC group was outpatient services 
(Hughes et al., 2000).   
These disparate findings could be a result of the differences between VHA HBPC 
programs and differences in study designs.  The majority of studies that found cost 
savings were single-site studies, whereas, the higher cost findings were found among 
the study of 16 VHA HBPC programs.  These differences support the need for further 
research that includes multiple VHA HBPC sites. 
Other research on VHA HBPC. Other research suggested that VHA HBPC 
enrollees could benefit from in-home pharmacy evaluations to increase adherence to 
medication compliance (Hsia Der, Rubenstein, & Chov, 1997).  Recently, VHA HBPC 
patient records were used to determine the applicability of using the Medication 
Appropriateness Index to monitor medication adherence, efficacy, and adverse events 
(Davis, Hepfinger, Sauer, & Wilhardt, 2007).   
Another study examined the characteristics associated with VHA HBPC 
enrollment among those with mental health diagnoses.  It was determined that VHA 
HBPC enrollees with mental health diagnoses are more likely to be older, male, 
divorced, separated, or widowed, suffer greater service-related disability, have a VA 
pension, and have higher incomes compared to those that did not utilize VHA HBPC 
(Miller & Rosenbeck, 2007). It was also found that VHA HBPC enrollees with mental 
health diagnoses were less likely to be diagnosed with drug abuse or dependence but 
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were more often diagnosed with all other mental health diagnoses, most commonly 
Alzheimer’s disease or dementia (Miller & Rosenbeck, 2007).  VHA HBPC enrollees 
with mental health diagnoses had greater morbidity and were more likely diagnosed 
with chronic conditions like hemiplegia/paraplegia, diabetes, mild liver disease, 
rheumatologic disease, chronic pulmonary disease, cerebrovascular disease, and 
congestive heart failure (Miller & Rosenbeck, 2007).  
Limitations of the evidence on VHA HBPC.  Based on these data, VHA HBPC 
seems like a promising model of care, but worthy of further investigation.  A number of 
limitations are evident within the existing literature.  Specifically addressing the evidence 
on cost effectiveness, two of the studies (Cummings et al., 1990; Hughes et al., 1992) 
were conducted prior to the availability of cost data in VHA administrative patient 
records (1984-1987), had relatively small samples (N=171 and 419, respectively), and 
utilized only local data.  Hospital costs were based on 1985 average accounting costs 
per day.  Moreover, in the Edes, et al. (2006) study, cost savings from intensive care 
units and emergency departments were assumed to be zero and the sample size was 
34 patients.   
The evidence that suggested VHA HBPC is associated with fewer hospital days 
and number of hospitalizations should also be considered limited.  First, the Hughes et 
al. (1992) study uses local data from the 1980’s with a small sample size.  Second, the 
Edes et al. (2006) study reported a reduction of ICU and ED use based on a regression 
using data from only 34 patients.  Additionally, the confidence intervals raise doubt 
regarding the conclusions that can be drawn from this evidence.  Moreover, the time 
examined was based on 120 days after enrollment compared to two years prior to 
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enrollment.  Chang et al. (2009) based their findings on local data which only measured 
six months pre- and post-enrollment, used only t-tests, and did not have a comparison 
group.  Finally, patient outcomes in terms of survival time were determined based on 
simple means tests without covariate accountability.   
There are several reasons why the above limits the evidence on the 
effectiveness of VHA HBPC.  First, when studies use only a pre-post design and do not 
have a control or comparison group, there could be selection bias in the sample.  
Selection bias can undermine the findings due to prior group differences that existed in 
the selected sample rather than differences based on participation in VHA HBPC.  This 
is why a comparison group, at a minimum, is vital to understanding a program’s effects. 
Using simple averages to determine patient outcomes in terms of survival does 
not take into account the multitude of factors that affect survival.  Several techniques, 
like regression-based survival analysis, take into account not only the time until event, 
but also accounts for covariates that can potentially confound the relationship between 
the entry into the observation period and the event.  Likewise, more robust statistical 
estimations are needed to confirm the earlier findings using national data.  Therefore, 
the current literature regarding VHA HBPC’s impact on service use, cost, and survival 
remain unclear.   Thus, the current study aims to expand the evidence associated with 
VHA HBPC by using national data with a comparison group to examine service 
utilization, average total expenditures, and survival.   
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Chapter 2: The Present Study 
  The overall goal of the proposed study is to determine the impact of VHA HBPC 
on service utilization, expenditures, and survival.  This section describes the study 
objectives, the logic model used to develop the hypotheses, and the theoretical 
framework used to conceptualize the relationship between the factors of interest.  
Finally, the aims and corresponding hypotheses are conveyed. 
 
Objectives 
Although evidence exists regarding the effectiveness of VHA HBPC, more 
research is needed.  The current study aims to accomplish three objectives.  First, this 
study will examine the effect of VHA HBPC on major healthcare service use (i.e., 
hospital, nursing home, and outpatient care) paid for by the U.S. Department of 
Veterans Affairs (VA).2  Next, this study will examine the effect of VHA HBPC on total 
expenditures paid for by the VA.  Third, this study will examine whether VHA HBPC 
enrollees experience similar mortality and survival as compared to a matched 
concurrent cohort.   
This study is critical due to the rise in the number of Veterans that are 
homebound from traumatic brain injury, mental health issues, and spinal cord injuries, 
which is likely to increase the demand for VHA HBPC.  Although current evidence 
describes the VHA HBPC population as generally older with chronic comorbid 
                                                           
2 The VA is comprised of three sectors: the Veterans Health Administration (VHA), the Veterans Benefits 
Administration, and the National Cemetery Administration.  Reference to the VA refers to the Department 
as a whole whereas reference to the VHA refers specifically to the Veterans Health Administration. 
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conditions, the proposed study is significant to improving the care received by young 
and old Veterans alike who need medical care in the home.  
In addition to the overall effect of VHA HBPC on service use, cost, and survival, 
this study will look at specific strata including those age 85 and older, those with two or 
more comorbidities, and those who were diagnosed as recipients of palliative care.  The 
following describes the rationale for these specific examinations.  
Older Adults and VHA HBPC.  It is well-understood that healthcare costs 
increase dramatically for older adults who are approaching the end of life, often due to 
substantial disease burden and aggressive attempts to treat complex medical conditions 
(Chastek et al., 2012; Frederix et al., 2013; Hogan, Lunney, Gabel, & Lynn, 2001; Yu, 
Smith, Kim, Chow, & Weaver, 2008).  Conversely, other research suggests that older 
age is associated with less aggressive end-of-life care (Miesfeldt et al., 2012), including 
lower rates of hospitalizations (Menec, Lix, Nowicki, & Ekuma, 2007).  The average age 
of VHA HBPC enrollees is 76.7 years (Cooper et al., 2007), and therefore, it is important 
to examine the effect of VHA HBPC by those who are the oldest old. 
Comorbidity and VHA HBPC.  Comorbid conditions are common in the general 
population and resource use has been associated with the degree of comorbidity rather 
than the specific diagnosis (Starfiled et al., 2003).  Moreover, research suggested that 
comorbidity mediates the role between age and survival (Jung et al., 2012).  Given the 
average age of VHA HBPC enrollees and considering that the average VHA HBPC 
enrollee has 19.36 diagnoses that require continuous management (Cooper et al., 
2007), degree of comorbid conditions should be considered in this investigation. 
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Hospice and VHA HBPC.   Throughout the last decade, the VHA has focused 
on increasing access to hospice care through a variety of initiatives which resulted in an 
increase in the number of inpatient deaths in hospice bed sections and an increase in 
referrals to community hospice providers (Department of Veterans Affairs, 2011). The 
implications of the increased use of hospice care among VHA HBPC enrollees are 
important given that hospice care has been associated with decreased health care 
costs near the end of life in some studies (Brumley et al., 2007; Kelley, Deb, Du, 
Carlson, & Morrison, 2013; Penrod et al., 2010) and an increase in others (Emanuel et 
al., 2002; Pyenson, Connor, Fitch, & Kinzbrunner, 2004).   
Considering that those who are receiving hospice would have different health 
service patterns as a result of this service and that many of the previous studies on VHA 
HBPC selected a sample that included only those with terminal illnesses, it is necessary 
to examine the effect of VHA HBPC by identifying those that received such services.  
Additionally, this type of examination is needed given that many die while enrolled in 
VHA HBPC.   
 
Logic Model  
 The logic model presented here proposes that a vulnerable population who 
needs healthcare services due to a variety of comorbidities and disability, experience 
disease exacerbation, a lack of disease management, and a lack of coordination of care 
without VHA HBPC (Figure 1).  This population is in need of services but cannot leave 
the home to access those services.  Therefore without VHA HBPC, service use, such as 
avoidable hospitalizations and nursing home use, increases along with expenditures.  
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This logic model assumes that the intervention of VHA HBPC will help patients manage 
their diseases and symptoms and receive the necessary coordination of care that is 
associated with a decrease in avoidable services, e.g., hospitalizations, which should 
decrease expenditures.  This logical model stems from Andersen’s behavioral model, 
described below.  
 
Without VHA HBPC 
 
With VHA HBPC 
 
 
 
Figure 1. Logic Model to Understand Why One Should Expect VHA HBPC to 
Decrease Service Utilization and Cost. 
*This model is influenced by Andersen’s behavioral model, discussed below. 
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Theoretical Framework: Andersen’s Behavioral Model 
Andersen’s (1973) behavioral model is a model frequently applied to health 
service research and can be applied as a framework for the current investigation.  This 
model is comprised of three determinants that explain health services utilization.  The 
first of these determinants is predisposing characteristics which include demographic 
characteristics (e.g., age, sex, and race).   The basic notion related to predisposing 
characteristics is that some individuals with certain characteristics will be more likely 
than others to use health services regardless of the fact that these predisposing 
characteristics are not directly related to health services.  
The second determinant is referred to as enabling resources.  Enabling 
resources include family (e.g., income, health insurance) and community characteristics 
(e.g., price of health services, ratio of health personnel to the population).  Specifically, 
individuals must have the means to receive services. Additionally, access to health 
facilities and the appropriate personnel have to be available in order for persons to 
receive services.  As such, these factors can either enable or prohibit an individual’s 
receipt of health care services.  For example, a study found an association between 
disparities in physician utilization and enabling factors (i.e., level of income and health 
insurance status) after adjusting for predisposing factors and need for care (Blackwell, 
Martinez, Gentleman, Sanmartin, & Berthelot, 2009). 
The final determinant to explain health services utilization is need and the 
perceived need for healthcare.  How individuals view their health, how they experience 
health symptoms, and the ideas they attach to this experience is of importance when 
considering health services utilization.  For example, research underscores the 
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importance of the need of services when determining service use for bereavement 
services (Bergman, Haley, & Small, 2011).  Additionally, awareness of unmet needs has 
been linked to the use of home- and community-based service utilization (Chen & 
Thompson, 2010).  Finally, Elhai et al. (2008) found that predisposing and enabling 
factors were associated with outpatient utilization among Veterans, but need factors 
provided an additive effect over predisposing and enabling variables accounting for the 
strongest effects.   
 
 
 Predisposing Factors 
Enabling Factors 
Need Factors 
OUTCOMES 
Health Services Use Health Services Cost Mortality 
Age 
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Figure 2. Health Behavior Model for VHA HBPC 
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Predisposing Factors.  The typical enrollee of VHA HBPC has characteristics 
that are commonly associated with those that have complicated post-hospital transitions 
of care (Kind, Smith, Frytak, & Finch, 2007) which can lead to higher service use such 
as being older, male, and African American (Chang et al., 2009; Hughes et al., 2000).  
Therefore, age, race, and sex will be accounted for in this study. 
Enabling Factors.  VHA HBPC enrollment in itself could be an enabling factor 
associated with healthcare use.  Related to VHA HBPC enrollment is geographic 
location.  While almost all VA medical centers offer VHA HBPC, living within a specified 
distance of these services could affect access to services.  Research on Veterans 
suggests that rurality status is associated with service use and medical costs (Bailey, 
Manning, & Peiris, 2012).  Additionally, insurance status has been linked to physician 
utilization (Blackwell et al., 2009).  In this case, VHA service connectedness serves a 
proxy for insurance status.  Service connectedness influences the amount of cost-share 
the Veteran can expect when utilizing services and is based on service history and 
disability status. 
Furthermore, hospice, by philosophical and regulatory definition, is associated 
with less aggressive care at the end of life.  For example, in a study examining 
emergency department use among those age 65 and older from 1992 to 2006, it was 
found that those that utilized hospice at least one month prior to death were rarely 
admitted to the emergency department (Smith et al., 2012). Therefore, hospice care 
could be considered an enabling, or more appropriately in this case, a prohibiting factor 
associated with certain types of care.  For these reasons, palliative care (in place of 
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hospice3), geographic location, service connectedness or eligibility (in place of 
insurance status), and likelihood of VHA HBPC enrollment will be accounted for in this 
analysis. 
Need Factors.  Need is particularly important in an older Veteran population 
which has experienced an increased clinical complexity and dependency compared to 
age-matched non-Veterans (Shay & Burris, 2008).  Additionally, those enrolled in VHA 
HBPC are by enrollment criteria, those who are in need of healthcare services.  
Therefore, comorbidities will be used as a proxy for need of services in this study. 
 
Aim 1 
This study will examine the effect of VHA HBPC on health service utilization. 
Hypothesis 1. It is expected that VHA HBPC will have an effect on health 
service utilization by decreasing nursing home use and acute hospitalizations and by 
increasing outpatient service utilization.   
 
Aim 2  
This study will examine the effect of VHA HBPC on total healthcare expenditures 
paid by the VA. 
Hypothesis 2. It is expected that VHA HBPC is associated with lower total 
healthcare expenditures due to expected decreased nursing home use and acute 
hospitalizations. 
                                                           
3 Hospice care is compassionate care for those facing a life-limiting illness or injury provided through a 
team approach to medical care, pain management, and emotional and spiritual support specific to the 
patient’s preferences (National Hospice and Palliative Care Organization, n.d.-a).  Palliative care is 
patient and family-centered care that anticipates, prevents, and treats suffering throughout the continuum 
of the illness addressing physical, intellectual, emotional, social, and spiritual needs (National Hospice 
and Palliative Care Organization, n.d.-b).  A distinguishing characteristic between these two related types 
of care is that palliative care can be provided concurrently with curative or life-prolonging care.  
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Aim 3 
This study will examine if there is a survival differential associated with VHA 
HBPC enrollment. 
Hypothesis 3.  It is expected that VHA HBPC is associated with differential 
survival.   
 
Method 
Data Sources. The VHA system is ideal for examining service utilization and 
expenditures because of the fact that all VHA healthcare providers are part of a 
centralized reporting system which makes the VHA the single largest integrated 
healthcare system in the U.S.  Specifically, the Veterans Integrated Health Systems and 
Technology Architecture, or VISTA, is the health information system that captures 
information on daily operations at all VHA facilities for both inpatient and outpatient 
services at the patient level through the use of electronic health records.  VISTA is 
decentralized but data is extracted from VISTA to create national datasets (Barnett, 
2003).   
Decision support system (DSS).  The extracted VISTA data is the main source 
for the database referred to as DSS.  DSS is an activity-based allocation system which 
uses DSS Identifiers, also referred to as “stop codes” to collect workload information, 
support patient care continuity, resource allocation, performance measurement, quality 
management, and third-party collections (Veterans Health Administration, 2008).  This 
coding system has been nationally implemented since 1999 and indicates who provides 
specific clinic products.  
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DSS Identifiers are six digits comprised of a primary and secondary coding 
scheme.  The first three digits (i.e. the primary code) indicate the type of services 
provided followed by the second three digits (i.e. the secondary code) which indicate the 
secondary modifier. These codes were used to identify VHA service utilization and 
expenditure information at the patient level from inpatient and outpatient files.   
Purchased care files. The VA makes payments to non-VHA providers when 
care is needed for a Veteran that the VHA cannot provide.  This information is 
accessible from the Purchased Care files, formerly known as the Fee Basis files.  This 
study utilized inpatient purchased care files to determine non-VHA acute 
hospitalizations that were paid for by the VA.   Patient identifiers enable merging across 
data files.   
Vital status file.  The VHA Vital Status Files contains mortality data from multiple 
VHA and non-VHA sources (i.e., Medicare Vital Status File and the Social Security 
Administration) (Veterans Health Administration, 2014). The file contains information 
including social security number, date of birth, gender, and date of death. 
Measures.  The following are operationalizations of the variables in this study.   
VHA HBPC. VHA HBPC enrollees were identified through DSS by the utilization 
codes of 156 (psychologist), 157 (psychiatrist), and 170-177 (physician; registered 
nurse, registered nurse practitioner, physician assistant, or licensed practical nurse; 
nurse extender or physician extender; social worker; therapist [recreation, physical, or 
occupational]; dietician; clinical pharmacist; telephone; other).  VHA HBPC status was 
dichotomized (1=VHA HBPC enrollee, 0=not enrolled in VHA HBPC) and used as a 
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treatment indicator to determine associations with health services utilization, 
expenditures, and survival.   
Initial treatment date.  To determine when to start analyzing the use and cost of 
services, the initial treatment date was used as day one.  For the treatment group, the 
initial treatment date was the first date of VHA HBPC utilization.  For the comparison 
group, the initial treatment date was the first date of an outpatient utilization after the 
beginning of the study period (the first day of FY 2009, i.e., October 1, 2008). 
Healthcare utilization. Health services were categorized into nursing home care, 
acute hospitalizations (VHA and non-VHA), and outpatient utilizations.  These variables 
were constructed separately as dichotomous variables (yes/no).  Additionally, counts of 
service utilization were constructed for hospitalizations and for outpatient utilizations.  
Hospitalization was determined by a claim for inpatient utilization.  
Hospitalizations were included in the analysis if they occurred after the initial treatment 
date and before the end of the study period (i.e., September 30, 2012). 
The number of past hospital utilizations was identified by inpatient hospitalization 
codes in FY 2008 and was used in the case/control matching technique (values were 
binary indicators of 1, 2, or 3 or more with zero past hospitalizations being the reference 
category). The number of hospitalizations after the initial treatment date were calculated 
as an outcome variable. 
Nursing home utilization was identified through the outpatient files (values 650, 
651, 653, and 654). Nursing home utilization was included in the analysis if utilization 
occurred after the initial treatment date and before the end of the study period 
(September 30, 2012). 
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Palliative and bereavement care. Considering that many VHA HBPC users are 
in the program at the end of life, ICD-9-CM procedure codes were used to determine 
use of palliative care (V66.7) or bereavement services (V62.82).  The utilization of 
hospice care was considered but the data were not ideal to examine hospice use.  
Therefore, the use of the ICD-9-CM code V66.7 was used as a proxy for recipients of 
hospice care since hospice-specific codes weren’t implemented throughout the VHA 
until FY 2012.  Also, because such codes could be associated with the likelihood of 
death, they were identified as separate binary indicators and used to predict VHA HBPC 
treatment in the case/control matching technique.  Up to 20 ICD-9-CM primary 
diagnosis codes, sourced from the outpatient file, were used to determine the receipt of 
palliative care or bereavement services. 
Expenditures.  Cost information for care provided by the VHA is available 
through DSS.  These costs are considered total costs of care (i.e., direct and indirect). 
The Purchased Care files also contain cost information for the amount the VA paid for 
non-VHA inpatient utilization, which were also included in this study.  Cost information 
was constructed separately for VHA-provided services including hospital, nursing home, 
and outpatient services, and for non-VHA provided inpatient hospital services. These 
services were summed to determine total cost of care. 
Demographics. All demographic variables were identified by DSS, including age, 
race, and service eligibility. Age was defined in years and represents baseline age.  Sex 
was identified based on the dichotomous variable sex from the VHA Vital Status File 
and outpatient DSS files.    
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Race was derived from outpatient DSS files and was defined as: Black or African 
American, White, and other.  Additional categories of race and ethnicity were available 
but these groupings had numbers too small to be informative in the analysis and were 
therefore categorized as other.  Due to the high rate of missingness on the race variable, 
a ‘missing race’ category was created in order to retain all available information and 
cases in the analyses while maintaining the integrity of the race values that were 
available.  Dummy indicators were constructed for Black, other, and missing, with white 
as the reference category.   
Veteran eligibility is based on categories representing the degree of disability 
related to serving in the service and the degree of impairment.  Not being service 
connected was compared to all other eligibility categories as a binary indicator. 
Geographic location was considered for the model, but a recent study suggested 
that distance from a VHA medical center was an effective instrumental variable for 
determining the risk of hospitalization (Edwards, Prentice, Simon, & Pizer, 2014).  
Instrumental variables are not recommended for use in matching algorithms.  Therefore, 
geographic location was not included, but was examined after the matches were 
selected and the determination was made that there was not a significant difference 
between the treatment and comparison groups in miles to the nearest VHA medical 
center offering VHA HBPC. 
Comorbidity.  The DSS variable ‘Primary Diagnosis’ uses ICD-9-CM codes to 
discern patient morbidity.  Up to 20 ICD-9-CM codes, sourced from the outpatient file at 
baseline, were used to determine patient comorbidity. The ICD-9-CM codes used in this 
analysis were identified at baseline and were constructed into separate binary indicators 
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based on the Elixhauser method (Elixhauser, Steiner, Harris, & Coffey, 1998).  While 
other methods of measuring morbidity exist, the Elixhauser method has shown superior 
performance compared to others, such as the Charlson index (Southern, Quan, & Ghali, 
2004).  The mutually exclusive morbidity categories used here were: congestive heart 
failure, cardiac arrhythmia, valvular disease, pulmonary circulation disorders, vascular 
disorders, hypertension uncomplicated, hypertension complicated, paralysis, 
neurological disorders, chronic pulmonary disease, diabetes, hyperthyroidism, chronic 
kidney disease/renal failure, liver disease, lymphoma, metastatic cancer, cancer without 
metastasis, rheumatoid arthritis/collagen, coagulopathy, weight loss, obesity, anemia, 
alcohol/drug abuse, psychoses, and depression.  A separate variable was created to 
account for comorbidity by identifying if a patient had two of more of any of the 
Elixhauser categories. 
Mortality.  The date of death for subjects in this study was ascertained from the 
VHA Vital Status File.  To examine survival, the difference between the initial treatment 
date and the date of death was calculated.  If death did not occur, survival time 
represented the difference between the initial treatment date and the end of the study 
period (i.e., September 30, 2012). 
Study Design. In order to examine the impact of VHA HBPC, a retrospective 
cohort design was utilized.  The cohort under investigation was selected from FY 2009 
and FY 2010 (i.e., the baseline period) and was followed through FY 2012.   
Similar to another recent examination of VHA HBPC (Edwards et al., 2014), the 
treatment (VHA HBPC) cohort was selected by identifying patients who had more than 
one VHA HBPC utilization during the baseline period. If there was only one VHA HBPC 
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utilization, the patient was not considered a VHA HBPC participant, and thus, was a 
potential control.  This is because having only one utilization likely indicates an 
assessment for VHA HBPC that did not result in program enrollment. Additionally, to be 
included in the treatment cohort, VHA HBPC enrollees had to be first-time participants 
in the program, determined by a two year look back which identified those who had VHA 
HBPC utilization during FYs 2007 or 2008.  These cases were removed from the 
analyses. 
All covariates (i.e., demographics, clinical characteristics, and frequency of past 
hospitalizations) were selected at baseline and compared by treatment status to 
determine if bias was present based on participation in VHA HBPC.   In this study, all 
covariates were used as binary indicators, and therefore, were compared using chi-
square goodness-of-fit tests.  As will be described in detail in the results, all but one of 
the covariates were significantly different based on participation in VHA HBPC.  These 
baseline differences between groups necessitated the control for confounding by the 
use of propensity matched scores to identify an appropriate comparison group.  
Propensity matching uses predicted probability of group membership obtained 
from a logistic regression model based on observed predictors. Propensity matching 
reduces the imbalance of the observed baseline characteristics between two groups by 
matching individuals based on the probability of exposure to the treatment, in this case, 
participation in VHA HBPC. Various methods of utilizing propensity scores exist (e.g., 
stratification based on the propensity score, regression adjustment, inverse probability 
weighting), but matching based on probability of treatment is believed to produce more 
precise estimates compared to other methods (Austin, 2007).   
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Since selecting a propensity method is somewhat subjective, a review of 
propensity score methods was conducted and it was concluded that matching is 
recommended when the data are appropriate for this method (Austin, 2007, 2009b, 
2014).  Other methods have limitations including extreme weights being common with 
inverse probability weighting which could be due to violations of the positivity 
assumption (Vittinghoff, Glidden, Shiboski, & McCulloch, 2012).  Additionally, 
stratification of the propensity score can cause residual confounding (Vittinghoff et al., 
2012),  has been shown to produce the greatest bias, and is not recommended for use 
with time-to-event outcomes (Austin & Schuster, 2014). Type I errors tend to be higher 
in methods other than matching (Austin & Schuster, 2014). Therefore, although there is 
subjectivity in the selection of the method of propensity score modeling, matching is 
highly regarded and recommended if the data and study design are appropriate, as was 
the case in this study.  Given this, and the robustness of the data, the matching 
technique was selected. 
Statistical Analysis. All analyses were conducted in SAS 9.2 (SAS Institute Inc., 
2009).  
Sample. In this study, to generate patient-specific propensity scores to determine 
probability of participating in VHA HBPC, a multivariate logistic regression was used.  
All observed covariates that were predicted to be associated with the outcomes were 
included in the model, i.e., all covariates previously described.  Specifically, these 
included: age (in years: 65-74, 75-84, 85-111; reference category: 0-64 years), sex 
(male=1), race (Black, other, missing; reference category: white), 25 comorbidities 
(dichotomous indicators), the number of comorbidities (two or more compared to less 
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than two), select ICD-9-CM procedures (i.e., palliative care and bereavement), and 
service eligibility (not service connected compared to all other eligibility, dichotomized). 
All variables were binary. 
After the propensity scores were generated via multivariate logistic regression, 
the population was then randomly sequenced and matched one control to one treatment, 
which is the recommended number of case-controls (Austin, 2010), without 
replacement,4 using nearest neighbor5 matching with a caliper6 distance of 0.20 of the 
standard deviation of the logit of the propensity score.  The caliper distance of 0.20 of 
the standard deviation of the logit of the propensity score has been validated as yielding 
optimal performance when estimating treatment effects (Austin, 2009b; Y. Wang et al., 
2013).  By applying a caliper parameter to the match, the proportion of the standard 
deviation of the logit of the propensity score is defined.  In other words, if the standard 
deviation of the control is more than 0.20 from the standard deviation of the logit of the 
propensity score of the treatment case, it is not selected as a match.  The random 
generation will continue to the next randomly selected case and determine if the 
propensity score is within the selected 0.20 allowable range.  This process continued 
until all cases were matched to controls. 
Next, the distributional probabilities of cases and controls were compared to 
determine that the overlap assumption was met to allow for the analysis of outcomes 
                                                           
4 Without replacement indicates that matched controls cannot be placed into the pool of potential controls 
to be matched for another treatment case (Stuart, 2010).  In other words, each matched control is a 
unique case. 
 
5 Nearest neighbor refers to selecting a case from the control group that is closest to, i.e. smallest 
distance from, the propensity score of a treatment case (Stuart, 2010). 
 
6 A caliper refers to the fixed allowable distance between the treatment case and the matched control 
case (Stuart, 2010). 
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between comparable groups.  To do this, the distribution of the propensity scores were 
examined by VHA HBPC status.  Then, the distributions of the observed covariates 
were checked by evaluating standardized differences by VHA HBPC status to confirm 
that the propensity scores created a balanced distribution between groups, of which, 
less than 10% is considered balanced (Austin, 2009a).   After ensuring the overlap 
assumption was met, analyses of the outcomes were conducted. 
Aim 1.  Healthcare services were analyzed by VHA HBPC status using 
descriptive statistics to indicate the rates of utilization.  McNemar’s test of significance 
was applied to determine if there was a statistically significant difference between VHA 
HBPC status and service utilization. McNemar’s test was necessary to account for the 
matched study design. 
In this analysis, multivariate statistics were not necessary to determine whether 
VHA HBPC enrollment significantly impacted healthcare service utilization since all 
covariates have been adjusted by the use of propensity score matching. Furthermore, 
previous research suggested that samples generated via propensity score methods can 
result in biased estimation of conditional odds ratios, like those produced by logistic 
regression models (Austin, 2007).  Austin et al. (2007) posited that when using matched 
samples based on propensity scores, odds ratios produce sub-optimal performance 
whereas methods that measure differences in proportions or means have superior 
performance over odds ratios. Therefore, relative risks are recommended in propensity-
matched studies since these methods outperform odds ratios in the decrease of the 
mean-squared errors.  
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Relative risks were calculated for each service category. By utilizing this type of 
study design and analysis, the results allowed conclusions to be drawn as to the 
association between VHA HBPC enrollment and specific types of service utilization 
relative to the comparison cohort.   
Aim 2.  Descriptive statistics were used to indicate how VA expenditures varied 
by VHA HBPC status by describing total average expenditures over the duration of the 
study period and by describing average expenditures specifically by nursing home care, 
hospitalization (VHA and non-VHA), and outpatient utilization.  
Then, generalized linear models (GLM) with gamma link and log functions were 
used to examine whether there was a statistically significant difference in the average 
cost of care by VHA HBPC status.  This modeling technique was appropriate for 
healthcare expenditures due to the nature of heteroscedasticity and skewness in the 
cost distributions while retaining the original dollar scale of the data (Blough & Ramsey, 
2000).  The models were weighted based on how many days each individual was 
observed in the study.   
Aim 3. To determine if there was a significant difference in survival by VHA 
HBPC status, bivariate relative risk analysis was first conducted.  Then, the examination 
of survival (i.e., dead or alive) time (in days) by VHA HBPC status was determined by 
utilizing a Cox proportional hazards model.  In the current study, observations were right 
censored which was accounted for by the Cox proportional hazards model.  Since this 
time-to-event analysis was conducted using the matched sample which adjusted 
confounding factors, the only additional adjustments made in the Cox regression model 
were exposure to treatment (i.e., participation in VHA HBPC) and quintile of the logit of 
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the propensity score.  A robust estimator of variance is used to account for the lack of 
independence between groups due to clustering from matching.  The event in this study 
is death (=1) or survival (=0).  The origin of time was based on the initial treatment date.  
Time was scaled in days. 
 Sensitivity analyses.  Five sensitivity analyses were conducted to validate the 
findings from the original sample. The first sensitivity analysis selected a new 
comparison cohort using exactly the same method as described above.  The first 
validation comparison cohort was 100% unique from the original comparison cohort.   
A second sensitivity analyses used the original sample but selected only those in 
VHA HBPC that were in the program for 6 or more months.  This timeframe was 
selected because it is plausible that reducing service use is not possible immediately 
after an episode of disease or illness exacerbation, and because, this timeframe has 
been examined in other studies (e.g., Chang et al., 2009).  A third sensitivity analysis 
selected another comparison cohort using all the same covariates used to generate the 
propensity scores in the original sample except the variable ‘number of past 
hospitalizations’ was replaced in the logistic regression model with the variable ‘number 
of days since past hospitalization to initial treatment date’.   
The fourth sensitivity analysis selected the comparison cohort based on the 
implications from the previous analyses conducted in this study.  This included adding 
time to death and additional comorbidities to the matching algorithm and selecting the 
cohorts only after an occurrence of an inpatient hospitalization.  Time to death was 
created in quartiles and added to the matching model.  Also added to the model was the 
presence of the following comorbidities (based on ICD-9-CM primary diagnosis codes): 
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dementia, hip fracture or replacement, ulcer, pneumonia, respiratory failure, bone 
marrow failure, sepsis, and debility unspecified. These were selected based on recent 
research suggesting that claims data can be used to determine diminished functional 
status (Chrischilles et al., 2014).   The comorbidities selected were based on those that 
were not already in the matching algorithm and those that were coded using ICD-9-CM 
codes.   Due to the selection of the cohort to only those with a hospitalization, the initial 
treatment date represents the date of the baseline (FY 2009 or 2010) inpatient 
hospitalization. 
Finally, the fifth sensitivity analyses used the same cohort as the fourth but only 
included those VHA HBPC enrollees that utilized VHA HBPC for six months or more.  
This was done for the same reasons as stated above, because it is plausible that 
reducing service use is not possible immediately after an episode of disease or illness 
exacerbation, and because, this timeframe has been examined in other studies (e.g., 
Chang et al., 2009).  Therefore, the initial treatment date for the treatment cohort in this 
analysis is 180 days after the baseline (FY 2009 or 2010) inpatient hospitalization. 
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Chapter 3:  Findings 
Sample 
The sample was selected by identifying utilization of outpatient services 
beginning in FY 2009 through FY 2010.  During this timeframe, a total of 91,079 
patients were identified as using VHA HBPC services and a total of 6,307,081 patients 
were identified as non-VHA HBPC users.  Of the VHA HBPC users, a total of 25,190 
had only one VHA HBPC utilization.  These patients were not considered VHA HBPC 
enrollees but instead were used as potential controls.  The look-back period (FY 2007-
2008) identified 24,633 VHA HBPC users and these cases were discarded in order to 
select only new users of the program.  The final cohort for generating propensity scores 
was comprised of 41,256 new VHA HBPC enrollees and 6,308,140 potential controls 
(this selection is illustrated in Figure 3). 
To estimate the causal effects of participation in VHA HBPC using observational 
data from VHA administrative records, propensity scores were generated for matching 
to identify a comparison group with similar characteristics as those who participated in 
VHA HBPC.  A logistic regression was used and included age, sex, race, Elixhauser 
morbidity groupings, number of comorbidities, select ICD-9-CM procedures (i.e., 
palliative care and bereavement), and service eligibility to predict VHA HBPC enrollment.   
Propensity scores were generated for 6,349,396 patients and represented the 
predicted probability of participating in VHA HBPC.  The average propensity score was  
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Figure 3. Sample Selection 
 
0.01 (SD = 0.02) with a range from < 0.01 to 0.96 prior to matching.  After these 
propensity scores were generated via logistic regression, the population was randomly 
sequenced and matched one control to one treatment, without replacement, using 
nearest neighbor matching and a caliper distance of 0.20 of the standard deviation of 
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the logit of the propensity score to derive 41,244 matched pairs.  Applying the caliper 
method can result in unmatched treated cases if the propensity score of the control 
cases was not within the distance specified of the treated case (Austin, 2014).  In this 
analysis, 12 treated cases were not matched and not included in the analyses of 
outcomes.  The post-match average propensity score was 0.04 (SD = 0.08) with a 
range of < 0.01 to 0.90. 
 
 
Figure 4. Standardized Differences Between Treatment and Control Groups 
 
Given that the objective of this model was to balance observed covariates by 
reducing residual variance rather than to predict exposure to VHA HBPC, the balance of 
residual variance among covariates was examined in place of the usual examination of 
model fit.  In Figure 4, it is shown that the standardized differences (i.e., standardized 
mean differences in units of the pooled standard deviation to compare balance in 
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observed variables) before propensity score matching varied greatly compared to the 
standardized differences after propensity score matching.  Austin (2009a) recognized  
that there is no consensus on the acceptable level of balance between groups that is 
meaningful, but note that others have suggested standardized differences of 0.1 
(represented by the dashed line in Figure 4) or below, which was achieved.   
Moreover, Figures 5 and 6 show the change in the distribution of the logit of the 
propensity scores before and after matching.  Prior to matching, the logit of the 
propensity scores had non-parametric density estimates of the distribution among the 
potential comparisons.  This non-normal distribution of the propensity scores in the 
potential comparison group indicated that this group was not comparable to the 
treatment group prior to matching.  
After matching based on a caliper of 0.20 of the standard deviation of the logit of 
the propensity score, density estimates of the distribution of the propensity scores 
between groups was normalized.  From Figure 6, the display of the density of the logit 
of the propensity scores after matching, it can be concluded that the treatment and 
selected controls are comparable in terms of their likelihood to be treated by VHA HBPC 
given the observed covariates. The distributions of the logit of the propensity scores of 
both groups were nearly identical.    
The overlap assumption was met, also illustrated in Figure 6.  That is, there were 
controls throughout the entire range of the treatment group and vice versa.  This is 
important because at every level of the treatment group, there needs to be a 
comparison case, and likewise, at every level of the control group there needs to be a  
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Figure 5.  Density Plot of Propensity Scores Prior to Match 
 
Figure 6. Density Plot of Propensity Scores Post-Match 
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treatment case in order to continue with inferential analyses.  This is clearly depicted in 
Figure 6. 
Descriptive statistics of the sample characteristics before and after matching are 
provided in Table 1.  As noted above, all but one covariate had significant differences 
between the treatment and control groups prior to the match.  After matching, nearly all 
covariates were not significantly different based on treatment status.  The exceptions 
were age (0 to 64 years), number of past hospitalizations (3 or more), neurological 
disorders, cancer, and palliative care use.  Furthermore, distance from each patient’s 
residence (using zip code) to the nearest VA medical facility offering VHA HBPC was 
examined.  It was concluded that there was not a significant difference between 
treatment groups in the distance between residence and VA medical facility with VHA 
HBPC. 
Although the c-statistic typically indicates model fit, and in this case was 0.84, the 
presented diagnostic methods were appropriate and necessary to determine the 
adequacy of the matched sample generated by propensity scores via the logistic 
regression (Austin, 2009a; Vittinghoff et al., 2012; Westreich, Cole, Funk, Brookhart, & 
Sturmer, 2011).  Nevertheless, the results from the model are presented in Table 2.  
These results will not be interpreted given the objective of the model. As described, the 
model was used to generate the propensity scores of which the diagnostics proved the 
selected sample was balanced and comparable with the only observed difference being 
the exposure to treatment (VHA HBPC). 
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Table 1. Sample Baseline (FY 2009 & 2010) Characteristics of VHA HBPC vs. Comparison, Before and After 
Matching Based on Propensity to Participate in VHA HBPC  
         Before Matching            After Matching 
Variables     VHA HBPC   Comparison   VHA HBPC Comparison 
                    n=41,256   n=6,308,140    n=41,244  n=41,244      
   n (%)                            
Male  40,553 (98.3)   6,284,114 (99.6)**  40,542 (98.3)40,517 (98.2) 
Age (in years)      
 0-64 9,973 (24.2)    3,527,829 (55.9)** 9,973 (24.2) 9,716 (23.6)* 
 65-74 6,656 (16.1)  1,097,651 (17.4)** 6,656 (16.1) 6,732 (16.3) 
 75-84 12,856 (31.2)  1,056,689 (16.8)** 12,853 (31.2) 12,811 (31.1) 
 85-111 11,746 (28.5)  441,920   (7.0)**  11,737 (28.5) 11,880 (28.8) 
Race     
 Black 6,038 (14.6)   727,009 (11.5)** 6,037 (14.6) 6,072 (14.7) 
 Other 2,313  (5.6)    304,472   (4.8)** 2,312 (5.6) 2,335 (5.7) 
 White 26,839 (65.1)  3,468,822 (55.0)** 26,829 (65.1) 26,889 (65.2) 
 Missing 6,066 (14.7)  18,078,337 (28.7)** 6,066 (14.7) 5,948 (14.4) 
Service Eligibility     
 Not Connected 22,664 (54.9)  3,434,188 (54.4)* 22,660 (54.9) 22,692 (55.0) 
Number of Past  
Hospitalizations  
 1 4,715 (11.4)   219,093  (3.4)** 4,710 (11.4) 4,801 (11.6) 
 2 1,822  (4.4)  62,062  (1.0)** 1,819 (4.4) 1,713 (4.1) 
 3 1,649 (4.0)  41,962  (0.7)** 1,646 (4.0) 1,414 (3.4)** 
Comorbidities 
CHF 4,740 (11.5)  118,776  (1.9)** 4,734 (11.5) 4,691 (11.4) 
Cardiac Arrhythmia 4,521 (11.0)  312,524  (5.0)** 4,518 (11.0) 4,547 (11.0) 
Valvular Disease 750  (1.8)  58,557  (0.9)** 749 (1.8) 747 (1.8) 
Pulmonary Circulation 
   Disorders 430  (1.0)  16,712  (0.3)** 430 (1.0) 418 (1.0) 
Vascular Disorders 2,754  (6.7)  171,478  (2.7)** 2,752 (6.7) 2,855 (6.9) 
Hypertension,  
  Uncomplicated 17,478 (42.4)  2,245,724 (35.6)** 17,474 (42.4) 17,340 (42.0) 
            Hypertension, 
   Complicated 716 (1.7)   74,570  (1.2)** 716 (1.7) 655 (1.6) 
Paralysis 823 (2.0)  23,459  (0.4)** 820 (2.0) 854 (2.1) 
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Table 1. Sample Baseline (FY 2009 & 2010) Characteristics of VHA HBPC vs. Comparison, Before and After 
Matching Based on Propensity to Participate in VHA HBPC (Continued)  
         Before Matching            After Matching 
Variables (Continued)    VHA HBPC   Comparison   VHA HBPC Comparison 
                    n=41,256   n=6,308,140    n=41,244  n=41,244      
   n (%)                            
Neurological Disorders 3320 (8.1)  117,357  (1.9)** 3,314 (8.0) 3,505 (8.5)* 
Chronic Pulmonary  
   Disease 7658 (18.6)  517,967  (8.2)** 7,654 (18.6) 7,733 (18.8) 
Diabetes 14031 (34.0)  1,195,242 (19.0)** 14,024 (34.0) 14,062 (34.1) 
Hyperthyroidism 922 (2.2)  148,119  (2.4) 922 (2.2) 888 (2.2) 
Chronic Kidney Disease 2737 (6.6)  168,927  (2.7)** 2,733 (6.6) 2,686 (6.5) 
Liver Disease 518 (1.3)  49,724  (1.0)** 518 (1.3) 527 (1.3) 
Lymphoma 963 (2.3)  120,716  (1.9)** 963 (2.3) 930 (2.3) 
Metastatic Cancer 239 (1.0)  14,246  (0.2)** 239 (1.0) 272 (1.0) 
Cancer  
   (without metastasis) 4648 (11.3)  346,228  (5.5)** 4,647 (11.3) 4,892 (11.9)* 
Rheumatoid Arthritis 7054 (17.1)  1,171,772 (18.6)** 7,052 (17.1) 6,979 (16.9) 
Coagulopathy 317 (1.0)  27,542  (0.4)** 317 (0.8) 323 (0.8) 
Obesity 1139 (2.8)  234,935  (3.7)** 1,139 (2.8) 1,091 (2.7) 
Weight Loss 1278 (3.1)  46,235  (1.0)** 1,277 (3.1) 1,281 (3.1) 
Anemia 842 (2.0)  55,783  (1.0)** 840 (2.0) 837 (2.0) 
Alcohol/Drug Abuse 3739 (9.1)  632,754 (10.0)** 3,739 (9.1) 3,791 (9.2) 
Psychoses 2499 (6.1)  155,066  (2.5)** 2,496 (6.1) 2,556 (6.2) 
Depression 8464 (20.5)  1,158,969 (18.4)** 8,463 (20.5) 8,518 (20.7) 
2 or More Comorbidities 29,412 (71.3)  2,834,200 (44.9)** 29,400 (71.3) 29,482 (71.5) 
Bereavement 1,150 (2.8)  33,495  (0.5)** 1,144 (2.8) 1,110 (2.7) 
Palliative Care 3,750 (9.1)  27,488  (0.4)** 3,738 (9.1) 3,494 (8.5)* 
     M SD 
Average Number of Comorbidities  2.25 (1.2) 1.46  (1.2)** 2.25 (1.2) 2.26 (1.3)    
CHF Congestive Heart Failure 
*p < .05; **p < .001; each ‘no’ group was compared to the ‘yes’ group. 
Data Source: VHA DSS Outpatient and Inpatient Data Files, FY 2009-2010. 
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Table 2. Selected Multivariate Predictors of VHA HBPC Enrollment for Propensity Score Matching 
             Odds Ratio  95% Confidence Interval 
Male  0.46 0.43-0.50   
Age (in years)      
 65-74   2.04 1.97-2.10 
 75-84   4.53 4.39-4.66 
 85-112   9.95 9.65-10.26 
Race     
 Missing   0.64 0.62-0.65 
 Black   1.47 1.43-1.51 
 Other   1.04 0.99-1.08 
Service Eligibility     
 Not Connected   0.83 0.81-0.84 
Number of Past  
   Hospitalizations 
 1   2.35 2.27-2.43 
 2   2.83 2.68-2.98 
 3   3.57 3.36-3.79 
Comorbidities 
Congestive heart failure   2.64 2.55-2.73 
Cardiac Arrhythmia   1.26 1.21-1.30 
Valvular Disease    0.98 0.91-1.06 
Pulmonary Circulation Disorders   1.51 1.36-1.67 
Vascular Disorders   1.47 1.41-1.53 
Hypertension, Uncomplicated   1.01 0.99-1.04 
Hypertension, Complicated   0.58 0.53-0.63 
Paralysis   4.09 3.80-4.42 
Neurological Disorders   3.41 3.28-3.55 
Chronic Pulmonary Disease   1.79 1.74-1.84 
Diabetes   1.80 1.75-1.84 
Hyperthyroidism   0.79 0.73-0.84 
Chronic Kidney Disease   1.36 1.29-1.42 
Liver Disease   1.62 1.48-1.78 
Lymphoma   0.89 0.83-0.95 
Metastatic Cancer   1.18 1.03-1.36 
Cancer (without metastasis)   1.20 1.16-1.24 
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Table 2. Selected Multivariate Predictors of VHA HBPC Enrollment for Propensity Score Matching (Continued) 
             Odds Ratio  95% Confidence Interval 
Rheumatoid Arthritis   1.01 0.98-1.04 
Coagulopathy   1.06 0.94-1.19 
Obesity   1.05 0.99-1.12 
Weight Loss   2.11 1.99-2.24 
Anemia   1.30 1.21-1.40 
Alcohol/Drug Abuse   1.05 1.01-1.09 
Psychoses   2.31 2.21-2.42 
Depression   1.58 1.54-1.63 
2 or More Comorbidities   1.36 1.31-1.40  
Bereavement   2.99 2.80-3.19 
Palliative Care   8.76 8.42-9.12 
Bold indicates statistical significance at p < .05. 
Data Source: VHA DSS Outpatient and Inpatient Data Files, FY 2009-2010. 
 
Next, the propensity-score matched sample was used to determine the effect of the VHA HBPC on the outcomes of 
interest.  In this study, there are several outcomes of interest and each are described below using the described 
propensity-matched sample. 
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Aim 1 
 The overall objective of Aim 1 was to examine if there were differences in 
healthcare utilization between those in VHA HBPC and those in the comparison group.  
Table 3 describes the utilization rates by group.  Average differences between groups 
were tested with McNemar’s test to determine differences between any utilization 
(yes/no) of a service type and t-tests were used to determine differences between 
groups in the average number of utilizations for each service type. 
 
Table 3. Descriptive Statistics for VHA-Paid Healthcare Utilization Among Those 
in VHA HBPC and the Propensity-Matched Comparison Group, FY 2009-2012         
 VHA HBPC Comparison VHA HBPC Comparison   
      % (n)                X (SD)  
Any Hospitalization  
   (VHA and non-VHA)  54.55 (22,807) 35.57 (14,769)**   5.58 (7.08) 5.29 (7.72)** 
VHA Hospitalization 47.65 (19,654)  31.82 (13,125)** 1.47 (2.53) 0.90 (2.03)** 
Non-VHA Hospitalization 66.09 (7,938)  33.91 (4,073)**  3.18 (6.23) 3.08 (7.00)** 
Nursing Home 2.67 (1,101) 1.62 (668)** 
Outpatient    205 (170)  143 (137)** 
n =sample size; X = average; SD = standard deviation. 
**p < .001. 
Data Source: VHA DSS Outpatient and Inpatient Data Files, FY 2009-2012. 
 
Beginning with any hospitalization (VHA and non-VHA), a higher proportion of 
VHA HBPC participants (54.55% versus 35.57%) utilized acute hospital care (p < .001).  
The average number of hospital utilizations were similar between groups (VHA HBPC: 
5.58, comparison: 5.29), but this small difference was statistically significant (p < .001).  
Turning to inpatient VHA hospitalizations, there was a lower proportion of patients in the 
comparison group (31.82%) who had an inpatient VHA hospitalization compared to 
those in VHA HBPC (47.65%; p < .001).  Additionally, the average number of inpatient 
VHA admissions was higher among those in VHA HBPC (X = 1.47, SD = 2.53) 
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compared to the comparison group (X = 0.90, SD = 2.03).  This difference was 
statistically significant, p < .001.  For non-VHA hospitalizations, the proportion of VHA 
HBPC participants who had an inpatient utilization was almost twice that of the 
comparison group (66.09% versus 33.91%).  Similarly, the average number of inpatient 
utilizations was higher among VHA HBPC (3.18 versus 3.08, p < .001). 
 The relative risk of hospitalization was higher among those in VHA HBPC for any 
hospitalization, VHA hospitalization, and non-VHA hospitalization (Table 4). 
 
Table 4. Relative Risk of Hospitalization Among Those in VHA HBPC and the 
Propensity-Matched Comparison Group Including Subgroup Stratification,  
FY 2009-2012         
          RR   95% CI   
Any Hospitalization (VHA and non-VA) 1.53 1.51 – 1.56 
   VHA Hospitalization 1.50 1.47 – 1.52   
 Age 85 & Older  1.47 1.42 – 1.52     
 Two or More Comorbidities 1.40 1.37 – 1.42 
 Recipients of Palliative Care  0.84 0.81 – 0.87 
   Non-VHA Provided Inpatient Care 1.94 1.87 – 2.00 
 Age 85 & Older  1.65 1.53 – 1.78   
 Two or More Comorbidities 1.82 1.75 – 1.89  
 Recipients of Palliative Care  0.94 0.87 – 1.03  
RR = Relative Risk; CI = 95% Confidence Interval. 
Bold indicates statistical significance at p < .05. 
Data Source: VHA DSS Inpatient Data Files and Purchased Care Files, FY 2009-2012. 
 
Post-hoc subgroup analyses were conducted to determine whether the effect of 
VHA HBPC on hospitalization risks differs in certain subgroups (Table 4).  These 
analyses revealed that, relative to the comparison group, the risk of hospitalization for 
those in VHA HBPC was significantly higher in nearly every subgroup for VHA and non-
VHA hospitalizations.  However, among those who received palliative care, those in 
VHA HBPC had a significantly lower risk of an inpatient VHA admission relative to the 
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comparison group (RR = 0.84, CI = 0.81 – 0.87).  There was a non-significant difference 
among recipients of palliative care for relative risk of non-VHA hospitalization.   
 Utilization of nursing home care was also examined.  The findings, represented 
in Table 3, indicate that a higher proportion of those in VHA HBPC (2.67%) utilized a 
nursing home compared to the comparison group (1.62%; p < .001).  Furthermore, the 
relative risk of a nursing home admission was significantly higher among those in VHA 
HBPC (RR = 1.65, CI 1.50 – 1.81).  Post-hoc sensitivity analyses revealed that, among 
the subgroups analyzed in this study, those with two or more comorbidities and those 
age 85 and older in VHA HBPC had a higher risk of nursing home utilization relative to 
the comparison group.  There was not a significant difference in the relative risk of 
nursing home utilization among who were recipients of palliative care. 
 
Table 5. Relative Risk of Nursing Home Utilization Among Those in VHA HBPC 
and the Propensity-Matched Comparison Group Including Subgroup Stratification, 
FY 2009-2012         
          RR   95% CI   
Nursing Home Utilization 1.65 1.50 – 1.81   
 Age 85 & Older  1.27 1.09 – 1.46   
 Two or More Comorbidities 1.73 1.54 – 1.94   
 Recipients of Palliative Care  1.08 0.76 – 1.54     
RR = Relative Risk; CI = 95% Confidence Interval. 
Bold indicates statistical significance at p < .05. 
Data Source: VHA DSS Outpatient Data Files, FY 2009-2012. 
 
 Not surprisingly, a t-test revealed that those in VHA HBPC had a significantly 
higher average number outpatient utilizations than those in the comparison group (203 
vs. 143, respectively; F = 1.44, p < .001).  Given that VHA HBPC is an outpatient 
program, higher outpatient utilizations was expected. Risk analyses were not conducted 
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for outpatient services since the use of outpatient services is expected among all 
patients and represents a much wider array of care. 
 Due to a high number of expected deaths in this sample, a final post-hoc analysis 
was conducted to provide further description of end-of-life care among those in VHA 
HBPC (Figure 7).  The overall rate of VHA hospitalization within 30 days of death was 
15.93% for those in VHA HBPC versus 14.93% for those in the comparison.  The rate of 
VHA hospitalization within 60 days of death was 21.78% for those in VHA HBPC versus 
18.81% for those in the comparison group, and finally, the rate of VHA hospitalization 
within 90 days of death was 25.04% for those in VHA HBPC versus 21.52% for those in 
the comparison group. 
 
 
 
Figure 7.  Rate of VHA Hospitalization at 30, 60, and 90 Days Prior to Death by 
VHA HBPC Status 
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Results revealed that at 30, 60, and 90 days prior to death, VHA HBPC participants 
were at significantly higher risk of a VHA acute hospitalization relative to the control 
group overall and by subgroup analyses except for recipients of palliative care (Table 6).  
Among those who received palliative care, VHA HBPC recipients had a lower risk of 
hospitalization across all intervals prior to death relative to the comparison group. 
 
Table 6. Relative Risk of Hospitalization Before Death Among Those in VHA HBPC 
and the Propensity-Matched Comparison Group Including Subgroup Stratification, 
FY 2009-2012         
          RR (95% CI) 
Intervals Prior to Death  30 Days  60 Days         90 Days 
Hospitalization (VHA) 1.11 (1.06 – 1.16) 1.16  (1.11 – 1.20) 1.16  (1.12 – 1.21) 
 Age 85 & Older  1.16 (1.08 – 1.26) 1.22  (1.14 – 1.30) 1.22 (1.15 – 1.29) 
 Two or More Comorbidities 1.08 (1.03 – 1.14) 1.12  (1.07 – 1.17) 1.11 (1.07 – 1.16) 
 Recipients of Palliative Care  0.69 (0.63 – 0.76) 0.73 (0.68 – 0.79) 0.75  (0.70 – 0.80) 
RR = Relative Risk; CI = 95% Confidence Interval. 
Bold indicates statistical significance at p < .05. 
Data Source: VHA DSS Inpatient Data Files and Vital Status Files, FY 2009-2012. 
 
 Overall, the findings for Aim 1 did not support the hypothesis that VHA HBPC 
would decrease risk of acute and nursing home care.  Stratification analyses revealed 
that these relationships did not vary by subgroup except among those who received 
palliative care.  There was generally no difference between groups among recipients of 
palliative care in the risk of hospitalization or nursing home care except during the time 
immediately prior to death for acute VHA hospitalization, which was the only findings 
that supported the hypothesis.  
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Aim 2 
 The objective of Aim 2 was to examine total average expenditures of healthcare 
paid by the VA for those in VHA HBPC relative to a comparison group over the duration 
of the study period.  GLM was utilized to account for the nature of cost data and was 
weighted by time in the study.  The average time in the study was 1,104 (SD = 208) 
days for those in VHA HBPC and 1,351 (SD = 248) for those in the comparison group (p 
< .001). The SAS procedure GENMOD was utilized with the specifications of a gamma 
distribution and a log link. 
Overall, findings revealed that recipients of VHA HBPC had a significantly higher 
average cost of care over the duration of the study period ($80,477 versus $42,325, p 
< .001). As displayed in Table 7, when examining specific types of services, all service 
costs were significantly higher among those in VHA HBPC relative to the comparison 
group.   
The mean cost of VHA HBPC over the duration of the study period was $17,667 
per patient.  When this cost was subtracted from the mean cost of outpatient care, VHA 
HBPC recipients had a mean cost of $30,396 for outpatient care over the duration of the 
study which was still a significantly higher average cost among VHA HBPC relative to 
the comparison group (p < .001). 
Table 7 displays the overall and post-hoc analyses by subgroups (i.e., the oldest 
old, those with two or more comorbidities, and those who received palliative care) which 
found that costs for VHA-provided services were significantly higher for VHA HBPC 
recipients for all service types examined among all subgroups over the duration of the 
study, with the exception for VHA hospital care among recipients of palliative care.   
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Table 7. Average VA Expenditures Over the Duration of the Study Among Those 
in VHA HBPC and the Propensity-Matched Comparison Group, FY 2009-2012        
             VHA HBPC ($)  Comparison ($)  
  Total Cost of VHA-Provided Services  80,477  42,325** 
 Hospital  32,387  17,788** 
 Outpatient Total  48,063  24,533** 
  VHA HBPC  17,667  -- 
  Non-VHA Provided Inpatient Care  5,329  2,508**  
Grand Total   85,808  44,833**   
   Age 85 & Older 
  Total Cost of VHA-Provided Services  61,231  31,399** 
 Hospital  21,922  14,394** 
 Outpatient Total  39,298  17,002** 
  VHA HBPC  20,332  -- 
  Non-VHA Provided Inpatient Care  4,049  2,566** 
Grand Total   65,280  33,966**  
   Two or More Comorbidities 
  Total Cost of VHA-Provided Services  84,837  47,299** 
 Hospital  34,847  19,921**  
 Outpatient Total  49,959  27,377** 
  VHA HBPC  18,017  -- 
  Non-VHA Provided Inpatient Care  5,362  2,575** 
Grand Total   90,202  49,875**  
   Recipients of Palliative Care 
  Total Cost of VHA-Provided Services  89,908  78,009** 
 Hospital  34,165  44,642** 
 Outpatient Total  55,710  33,345** 
  VHA HBPC  27,171  -- 
  Non-VHA Provided Inpatient Care  5,071  5,797 
Grand Total   94,983  83,807**  
*p < .05; ** p < .001 
Bold indicates the treatment group having significantly lower costs. 
Data Source: VHA DSS Inpatient and Outpatient Data Files and Purchased Care Files, FY 
2009-2012. 
 
Among VHA HBPC palliative care recipients, costs were $34,165 compared to $44,642 
for the comparison group recipients of palliative care (p < .001).  There was a non-
significant difference in cost between groups for hospital care over the duration of the 
study among those ages 85 and older (p = .07 for VHA and p = .29 for non-VHA). 
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The average cost of nursing home care over the duration of the study was $976 
for those in VHA HBPC and $1,134 for those in the comparison.  These numbers are 
skewed due to the low utilization rate of nursing home services (VHA HBPC: 2.67%, 
comparison group: 1.62%) which is likely why the models for nursing home care did not 
converge, and thus, significance is not reported.   
 
 
 
 
Figure 8.  Average Nursing Home Cost Over the Duration of the Study for Those 
with Greater Than $0 Costs 
Data Source: VHA DSS Outpatient Data Files, FY 2009-2012. 
 
When restricting the sample to only those who utilized nursing home care, the 
average was $34,201 for those in VHA HBPC and $42,492 for the comparison group 
over the duration of the study.  Figure 8 illustrates the difference in average costs 
between groups for only those with greater than zero costs.  In general, and among 
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those ages 85 and older, VHA HBPC seems to reduce the cost of nursing home care.  
However, for those with two or more comorbidities and for recipients of palliative care, 
average nursing home costs are higher among those in VHA HBPC. Significance levels 
are not reported since models did not converge. 
The hypothesis that VHA HBPC would be associated with an overall lower cost 
of healthcare for VHA-paid services was not supported.  Costs were generally higher 
among those in VHA HBPC with the exception of the costs associated with VHA acute 
hospitalizations among palliative care recipients. 
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Aim 3 
 The objective of Aim 3 was to examine if there was a survival differential 
associated with participation in VHA HBPC.  A total of 25,884 (62.79%) patients in VHA 
HBPC died during the study period compared to 17,834 (43.28%) patients in the 
comparison group (p < .001). As Table 8 shows, findings reveal that the risk of death 
was significantly higher among those in VHA HBPC (RR = 1.45, 1.43 – 1.47) relative to 
the comparison group.   
 
Table 8. Relative Risk of and Time to Death Among Those in VHA HBPC and the 
Propensity-Matched Comparison Group, FY 2009-2012         
        RR /Hazard Ratio  95% CI   
Died   
 Relative Risk  1.45 1.43 – 1.47 
 Survival Time 1.89 1.86 – 1.93  
RR = Relative Risk; CI = 95% Confidence Interval. 
Bold indicates statistical significance at p < .05. 
Data Source: VHA DSS Outpatient Data Files and Vital Status Files, FY 2009-2012. 
 
A Cox proportional hazards model with a robust variance estimator to account for 
clustering was fit to the matched sample to determine if there was a significant 
difference between groups in time to death. The model contained exposure to VHA 
HBPC and quintiles of the logit of the propensity score as predictors since covariate 
adjustment was already applied to the sample.  The average time to death was 979 
days (SD = 534), or just over two and a half years from initial treatment date for those in 
VHA HBPC, and 1,226 days (SD = 414), or three and a quarter years from initial 
treatment date for those in the comparison group.  This difference was statistically 
significant at p < .001.  The hazard ratio for mortality among those who participated in 
VHA HBPC was 1.89 (CI 1.86 – 1.93).  This indicates that those in VHA HBPC died 
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sooner, on average, than those who died in the comparison group.  This relationship is 
graphically displayed via Kaplan-Meier survival curves in Figure 9, below.  The solid 
blue line represents the survival estimates over time for the control group, which is 
significantly more favorable in comparison the survival estimates for those in VHA 
HBPC, represented by the dashed red line indicating sooner time to death. 
 
 
 
Figure 9. Survival Time From Initial Treatment Date Among Those in VHA HBPC 
and the Propensity-Matched Comparison Group, FY 2009-2012 
  
 
Time to Death 
VHA HBPC    Controls 
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Also revealed by the Cox proportional hazards model was the significance of the 
propensity score quintiles in predicting time to death.  All quintiles were significant 
predictors, and the higher the quintiles, the sooner death occurred (quintile 1: reference; 
quintile 2: HR = 1.84, 1.78-1.92; quintile 3: HR = 2.39, 2.31-2.48; quintile 4: HR = 3.08, 
2.97-3.19; quintile 5: HR = 4.64, 4.48-4.80).  This suggests that there is an association 
between time until death and the likelihood of VHA HBPC treatment. 
Post-hoc analyses were conducted to determine if the risk of death varied by 
subgroups (Table 9).  Results indicate that the rate of death was higher among those in 
the VHA HBPC subgroups of adults ages 85 and older (80.50% vs. 66.13%, p < .001) 
and those with two or more comorbidities (62.34% vs. 43.03%, p < .001) compared to 
the same subgroups in the comparison group.  Among recipients of palliative care, the 
comparison group had a higher rate of death (89.77%) compared to VHA HBPC 
(86.54%, p < .001).  Accordingly, the relative risk was higher among VHA HBPC 
recipients who were ages 85 and older (RR = 1.45, CI 1.43 – 1.47) and those with two 
or more comorbidities (RR = 1.22, CI 1.20 – 1.24).  However, among those who 
received palliative care, VHA HBPC recipients had a slightly lower relative risk of death 
(RR = 0.96, CI 0.95 – 0.98). 
 
Table 9. Post-Hoc Sensitivity Analyses to Examine Relative Risk of Mortality 
Among Those in VHA HBPC and the Propensity-Matched Comparison Group,  
FY 2009-2012 
          RR    95% CI            
Age 85 & Older 1.45 1.43 – 1.47  
Two or More Comorbidities  1.22 1.20 – 1.24  
Recipients of Palliative Care  0.96 0.95 – 0.98 
RR = Relative Risk; CI = 95% Confidence Interval. 
Bold indicates statistical significance at p < .05. 
Data Source: VHA DSS Outpatient Data Files and Vital Status Files, FY 2009-2012. 
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In sum, the results indicated that the hypothesis of a survival differential between 
VHA HBPC and the comparison group was supported by the evidence.  Recipients of 
VHA HBPC, in general, were at a higher relative risk of death and on average died 
significantly sooner relative to the comparison group.  The only exception was among 
recipients of palliative care, those in VHA HBPC survived slightly longer than those in 
the comparison group.  Considering the results of the three aims varied from 
expectations, several sensitivity analyses were conducted. 
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Sensitivity Analyses 
Multiple iterations of sensitivity analyses were conducted to either validate the 
reported findings or to better describe the effect of VHA HBPC taking into account the 
implications of the previously reported findings.  The first sensitivity analysis selected a 
new comparison cohort 100% unique from the original.  These results were nearly the 
same as the first and are not discussed here.  
The second sensitivity analysis used the original cohorts but redefined the 
treatment group as those in VHA HBPC for six months or more.  The third sensitivity 
analysis modified the original matching algorithm by replacing ‘the number of past 
hospitalizations’ with the ‘time since last hospitalization’.  In this cohort, there were 
40,368 matched pairs. Approximately 9% (3,630) of controls are the same cases 
between the first and third validation cohorts, but none are the same as the original 
control cohort (i.e., the third validation cohort was 100% unique from the original sample 
of controls). 
From the original comparison cohort to the fourth comparison cohort there was 
71% overlap in the control group.  This cohort was selected by refining the matching 
algorithm further to include time to death and additional comorbidities and selected the 
sample based on the occurrence of an inpatient hospitalization.  This group was 
comprised of 29,471 matched pairs.  Finally, the fifth round of sensitivity analyses used 
the fourth cohort but restricted the VHA HBPC cohort to only those that utilized the 
program for six months or more.   
The results for the relative risk of hospitalization and nursing home use are 
presented in Table 10. From the original analysis to the second sensitivity analysis, the 
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results were very similar to the original.  The only difference in significance was among 
recipients of palliative care in VHA HBPC who had a significantly lower risk of non-VHA 
hospitalization compared to recipients of palliative care in the comparison group from 
the second sensitivity cohort.  With one exception, all other analyses of risk for hospital 
or nursing home use remained significant, and in cases where there was an increased 
risk for hospitalization, the degree of increased risk lessen from the degree of risk in the 
original cohort to the second sensitivity cohort.  This indicates that the risk of the use of 
these services remains higher than the comparison group but the risk is tempered over 
time since the second sensitivity cohort only looked at the use of services among those 
in VHA HBPC for six or more months. 
Data for non-VHA hospitalizations were not available for the third sensitivity 
analyses.  Nevertheless, the results for the third sensitivity analyses suggest that the 
number of days since prior hospitalization did not change the results of the risk of 
service use, overall.  The risk for VHA hospitalization remained at levels indicated in the 
original  cohort and the risk for nursing home services that were significant in the 
original cohort remained significant in the third sensitivity analyses, but to a lesser 
degree than the original cohort. 
The fourth and fifth sensitivity analyses suggest that refining the matching 
algorithm by adding time to death and additional comorbidities, in addition to only 
including those with a baseline inpatient VHA hospitalization, impacts the effect of VHA 
HBPC on service use.  While the risk of VHA hospitalization remained higher for the 
VHA HBPC enrollees relative to the comparison group in general in the fourth sensitivity 
cohort, the risk of nursing home utilization was significantly less for VHA HBPC 
72 
 
enrollees overall and among VHA HBPC enrollees in the age strata of 85 years and 
older.  Among those with two or more comorbidities, the relative risk changed from 
significantly higher among VHA HBPC enrollees in the original cohort to significantly 
lower in the fourth cohort.  After restricting the fourth cohort to only those in VHA HBPC 
for six or more months (i.e., the fifth cohort), the lower risk of nursing home use among 
VHA HBPC enrollees from the fourth cohort was even lower in the fifth cohort.  
Additionally, the fifth cohort was the only cohort that showed significantly lower risks for 
VHA and non-VHA hospitalization relative to the comparison group.  This remained true 
for all strata examined.  The results indicate that time to death, selection based on 
hospitalization, and additional comorbidities are necessary when examining the risk for 
service use among VHA HBPC participants.  Additionally, these results indicate that the 
effect of VHA HBPC cannot be determined immediately, and six months after the initial 
treatment, different results should be expected. 
Table 11 describes the results of the sensitivity analyses for expenditures.  
Expenditures for the third sensitivity cohort were not examined since the use of services 
was very similar to the original cohort.  The results from Table 11 show that VHA HBPC 
enrollees incur significantly higher costs overall compared to a matched comparison 
group.  The only evidence of lower expenditures is in the fifth sensitivity cohort for VHA 
hospitalization, but this savings was not enough to produce lower expenditures overall 
among VHA HBPC enrollees relative to the matched comparison group. 
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Table 10. Relative Risk of Hospitalization Comparing the Original Cohort to Sensitivity Cohorts, Including 
Subgroup Stratification, FY 2009-2012         
Original Cohort  Second Cohort Third Cohort  Fourth Cohort    Fifth Cohort 
    (Original, (+Days Last Hospital) (+Death time &   (+Death time 
6 mo.)     Comorbidities)  Comorb., 6 mo.) 
RR   95% CI RR   95% CI   RR   95% CI RR   95% CI RR   95% CI 
Any Hospitalization (VHA & non-VA) 1.53 1.51 – 1.56 1.36 1.34-1.39    1.25 1.23 – 1.27 0.91  0.90-0.92 
   VHA Hospitalization    1.50 1.47 – 1.52 1.35 1.32-1.38 1.47 1.45 – 1.50 1.41 1.38 – 1.45 0.89  0.88-0.90 
 Age 85 & Older   1.47 1.42 – 1.52     1.35 1.30-1.41 1.47 1.42 – 1.52 1.42 1.35 – 1.50 0.82  0.80-0.85 
 Two or More Comorbidities  1.40 1.37 – 1.42 1.25 1.22-1.37 1.37 1.34 – 1.40 1.39 1.35 – 1.42 0.89  0.88-0.90 
 Recipients of Palliative Care 0.84 0.81 – 0.87 0.75 0.71-0.79 0.81 0.78 – 0.84 1.06 0.99 – 1.12 0.74  0.71-0.77 
   Non-VHA Provided Inpatient Care* 1.94 1.87 – 2.00 1.52 1.47-1.58    1.02 1.00 – 1.04 0.88  0.86-0.90 
 Age 85 & Older   1.65 1.53 – 1.78 1.39 1.28-1.50    1.02 0.98 – 1.07 0.88  0.84-0.92  
 Two or More Comorbidities  1.82 1.75 – 1.89 1.43 1.37-1.50    1.03 1.01 – 1.05 0.89  0.87-0.91 
 Recipients of Palliative Care 0.94 0.87 – 1.03 0.74 0.67-0.82    0.99 0.92 – 1.06 0.88  0.82-0.95 
Nursing Home Utilization    1.65 1.50 – 1.81 1.59 1.44-1.76 1.42 1.30 – 1.56 0.88 0.80 – 0.97 0.74  0.67-0.81 
 Age 85 & Older   1.27 1.09 – 1.46 1.23 1.06-1.44 0.99 0.87 – 1.14 0.62 0.53 – 0.73 0.54  0.45-0.64 
 Two or More Comorbidities  1.73 1.54 – 1.94 1.64 1.45-1.86 1.48 1.32 – 1.66 0.90 0.81 – 1.01 0.76  0.68-0.86 
 Recipients of Palliative Care 1.08 0.76 – 1.54     0.97 0.66-1.43 0.92 0.65 – 1.29 1.15 0.79 – 1.69 0.77  0.50-1.17 
*This data were not available for all cohorts. 
RR = Relative Risk; CI = 95% Confidence Interval. 
Bold indicates statistical significance at p < .05. 
Data Source: VHA DSS Outpatient and Inpatient Data Files, and Purchased Care Files, FY 2009-2012. 
 
Table 11. Average VA Expenditures Among Those in Original Cohort Compared to Sensitivity Cohorts        
            Fourth Validation  Fifth Validation 
Second Validation (+Death time &   (+Death time & 
     Original Sample  (Original: 6-mo.)  Comorbidities)  Comorbidities, 6 mo.) 
 
          HBPC Comparison  HBPC Comparison HBPC Comparison HBPC Comparison 
  Total Cost of VHA-Provided Service           80,477 42,325** 80,000 42,325** 107,950  69,125** 89,761 85,371** 
    Hospital  32,387 17,788** 23,348 18,111** 51,010  32,454** 46,107 48,693** 
    Outpatient Total 48,063 24,533** 34,563 24,700** 56,935   36,659**   43,680    36,659** 
  Non-VHA Provided Inpatient Care 5,329 2,508** 4,354    2,617** 13,008   13,198   11,071      13,198 
Grand Total  85,808 44,833** 87,294         46,121** 123,748   84,315** 103,358    100,519**  
** p < .001 
Bold indicates the treatment group having significantly lower costs. 
Data Source: VHA DSS Outpatient and Inpatient Data Files, and Purchased Care Files, FY 2009-2012.
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Chapter 4:  Discussion 
Summary 
The VHA characterizes quality care as: the right type of care; care that results in 
the best outcome; patient-centered care; and care free from harm and hazards (U.S. 
Department of Veterans Affairs, 2014).  As a central component to providing quality of 
care, the VHA strives to focus on what matters to the patient.  Thus, VHA HBPC 
remains a critical alternative to institutional care or care dependent upon caregivers by 
bringing health professionals to the patient.  By enabling patients to remain in their 
homes and receive care that they might otherwise forgo, the VHA is assisting patients in 
achieving their health-related goals.   
This study found that without accounting for critical factors (i.e., time to death, 
baseline hospitalization, and an additional array of comorbidities), VHA HBPC appeared 
to be associated with higher risk for hospital and nursing home use, higher expenditures, 
and higher risk of death.  However, the findings that indicated that VHA HBPC is 
associated with likelihood of death should be accounted for in analyses that assess the 
impact of VHA HBPC.  This is a major contribution of this study.  This is supported by 
other research suggesting that homebound individuals have a higher risk of death within 
two years compared to non-homebound individuals and suggest that homebound status 
should be considered an indicator of frailty (Herr, Latouche, & Ankri, 2013).  This 
difference in the original analyses and several of the early sensitivity analyses could 
explain why the program was not producing the expected results.   
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After accounting for time to death, baseline hospitalization, and additional 
comorbidities, the results were closer to the hypothesized outcomes.  Specifically, VHA 
HBPC can affect the relative risk of hospitalization after a certain period of longevity in 
the program.  In this study, six months was used as the point in time in which the 
relative risk was assessed.  After six months (and after the inclusion of additional 
comorbidities, time to death, and hospitalization as inclusion criteria), VHA HBPC 
participants had a lower risk of hospitalization and nursing home use relative to a 
comparison group, albeit higher total expenditures.   
Prior to the refinement of the matching algorithm and inclusion criteria, VHA 
HBPC recipients of palliative care had lower acute care utilization overall and 
immediately prior to death compared to a similar group of patients not receiving VHA 
HBPC.  Additionally, VHA HBPC recipients of palliative care survived longer than the 
comparison group.  These findings are highlighted because VHA HBPC participants 
have a high rate of death.  In this study, more than 62% of VHA HBPC participants in 
the original cohort died over a three year period.  Even after the refinement of the 
matching algorithm, recipients of palliative care generally had a lower rate of VHA 
hospitalization, overall. 
The question should be raised as to whether VHA HBPC is an end-of-life 
program.  The program seems effective in keeping participants receiving palliative care 
out of the hospital, especially during the 30 to 60 days prior to death in all cohorts, but 
further research is needed to better understand this association.  Moreover, the findings 
here are underscored by a previous study (Hughes et al., 1992) that similarly found that 
76 
 
VHA HBPC was effective in keeping patients home for longer in the time prior to death 
compared to a comparison group.  
 
Relation to Other Evidence 
The findings here are supported by those in the Hughes et al. (2000) study which 
found that those in VHA HBPC had higher costs than a randomized control group.  A 
difference between these results and the Hughes study is in the service utilization 
associated with costs.  In the Hughes study, only outpatient services were significantly 
reduced and home-based care and nursing home costs were significantly higher.  The 
results from this study suggest that outpatient services were not reduced, and generally, 
VHA HBPC participants had higher service use and cost across the board.  The 
differences in the details of costs are not surprising given the general inflation of 
healthcare costs over time.  Nevertheless, the “bottom line finding” regarding total costs 
was the same between studies: VHA HBPC did not reduce overall cost of care when 
compared to a similar control group.  
Previous studies finding reduced cost associated with VHA HBPC should not be 
overlooked.  Studies of VHA HBPC that found cost savings (Cummings et al., 1990; 
Hughes et al., 1992) were from the 1980’s and before a time when aggregated cost 
records were kept in administrative databases that would allowed for large scale 
analyses, like that conducted here.  A more recent cost analysis was conducted for 
Medicare’s Independence at Home program and suggested that participants had 
significantly lower costs, especially among the most frail (De Jonge et al., 2014).  
However, these two programs generally operate in two different systems of care, and 
although service utilization overlap occurs, direct comparisons between programs are 
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difficult.  A closer look at the most frail VHA HBPC recipients is warranted, but 
measures of frailty are difficult using administrative data.    
Based on the original analysis and early sensitivity analyses, this study did not 
support others that found a general reduction in hospital utilization associated with VHA 
HBPC or similar home-based primary care programs (Chang et al., 2009; Edes et al., 
2014; Hughes et al., 1992; Wajnberg et al., 2010).  However, these previous studies 
used pre-post enrollment designs.  For example, reduced utilization is what Edes et al. 
(2006) and Edes et al. (2014) found in their smaller study of the Missouri VHA HBPC 
program and a more recent, larger study of VHA and Medicare.  Specifically, VHA 
HBPC was considered cost effective from the perspective of the expected cost of VHA 
HBPC participants (based on pre-enrollment service use) compared to the observed 
cost (based on post-enrollment service use).   
The current study did not determine if there were service use reductions and cost 
reductions after admission to VHA HBPC compared to prior to VHA HBPC, as the 
aforementioned studies concluded.  The service use and cost trajectory could have 
been changed due to participating in the program, as previous evidence suggested, but 
this type of comparison was not the goal of the present study.  This study adds to the 
evidence base that, when compared to a similar group of patients receiving usual care, 
VHA HBPC does not reduce the relative risk of hospitalization initially, and VHA HBPC 
should not be characterized as lowering expenditures.   
In addition to the difference of a pre/post design versus comparative analyses, 
other differences in study designs exist that could explain the differences and 
similarities in findings between past research findings and those described here.  A 
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handful of studies examined disease specific populations rather than the entire program 
population, as was done in this study.  Edwards et al. (2014) examined enrollees with 
diabetes and found decreased hospital use.  Hughes et al. (2000) investigated those 
with two or more functional impairments, congestive heart disease, or chronic 
obstructive heart disease and found lower hospital readmission rates at six months.  
Edes et al. (2006) examined end stage heart and lung disease patients and found lower 
use and cost.  These findings are similar to those in the Medicare Independence at 
Home Demonstration that found the program effective for the frailest group of 
participants (De Jonge et al., 2014).  Similar to the findings presented here, Chang et 
al.’s (2009) study utilized a six-month post enrollment design, and like this study, found 
lower hospital use. 
 The findings here that evidenced a lower relative risk of death among those 
receiving VHA HBPC and palliative care are similar to the findings in a study examining 
the effect of palliative care on patient-reported outcomes and end-of-life care among 
patients with a new diagnosis of non-small-cell lung cancer (Temel et al., 2010).  In 
Temel et al.’s study, the mean survival time was 11.6 months for those receiving 
palliative care compared to 8.9 months for those receiving usual care (p = 0.02).  Other 
positive findings have been associated with the receipt of palliative care among complex 
patients.  For example, among Medicaid patients with cancer, palliative case 
management was associated with lower inpatient admissions, lower intensive care unit 
admissions, longer average days on hospice, and lower rate of death in the hospital 
compared to those in the comparison group (Wang, Piet, Kenworthy, & Dy, 2015).  The 
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overall favorable findings regarding VHA HBPC and palliative care warrant further 
investigation. 
 
Andersen’s Behavioral Model 
 Andersen’s behavior model was adapted for VHA HBPC was used to develop the 
conceptual model for this study.  Predisposing factors (i.e., age, race, and sex) were 
generally balanced between the control and treatment groups.  Proposed enabling 
factors in this study included geographic location, the receipt of palliative care, 
insurance status, and receipt of the VHA HBPC. It was determined through t-tests that 
there was not a geographic difference between the treatment and control group in terms 
of miles from individual’s residences and the VA medical center providing VHA HBPC. 
Therefore, geographic location likely did not impact the effects of the program on 
outcomes, overall.  Also balanced was the proportion of those service eligible which 
was the proxy for insurance status.   Due to data limitations, examining the effect of 
hospice was not enabled but it was determined that VHA HBPC recipients of palliative 
care had better outcomes in terms of lower service utilization than did the control group 
who received palliative care.  This effect was generally true across cohorts, and without 
more analyses, it is difficult to disentangle the effects of the program from the effects 
from receiving palliative care.   
 Two factors from Andersen’s Health Behavior Model likely influenced the results 
which were the receipt of VHA HBPC (an enabling factor) and need for care.  While 
diagnoses were used to account for comorbidity (as a proxy for need for care), the level 
of disease severity (and therefore, the precise level of need) was indiscernible.  After 
accounting for confounding by controlling for time to death, two groups that were more 
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similar in terms of likelihood for mortality-related processes (and possibly need for care) 
were created.  Therefore, need for care played a confounding role in the results in the 
first set of analyses, but after creating a control group that likely reduced residual 
variance, the enabling factor of receiving VHA HBPC had an effect by decreasing the 
risk of service use relative to the comparison group.  The strong influence of need was 
also described by others who found it to have influential effects in a Veteran population 
(Elhai et al., 2008). 
 
Interpretation, Limitations, and Future Research 
Given the higher average number of utilizations and higher relative risk of acute 
hospitalization relative to the comparison group in cohorts that did not restrict to six 
months of program enrollment, it is likely that there are one or more subgroups of VHA 
HBPC recipients who could be considered “frequent fliers”.  Past research has led to 
suggestions that those who experience complicated transitions from one setting to 
another after an acute hospitalization are more likely to be those who are more 
vulnerable and suffer disproportionately during care handoffs (Coleman, 2007).  If this is 
the case for VHA HBPC recipients, further research is critical to enhance the quality of 
care provided to these patients.  Future analyses should focus on high utilizers and 
transitional care for those in VHA HBPC.   
The results of high resource utilization are not surprising.  More care, in this case 
provided by VHA HBPC, can often lead to even more care, which in turn leads to higher 
costs.  A possible explanation for these findings are that, given that VHA HBPC 
recipients are in a program of care, their care could be monitored more closely than that 
of the comparison group yielding a “surveillance bias”.  This phenomenon is one 
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suggesting that the more you look, the more you find.  Since those in VHA HBPC are 
being provided care regularly, they may have a higher likelihood of receiving additional 
needed services.  Another scenario, not necessarily an alternate explanation, but 
perhaps additional possibility, is that VHA HBPC recipients are experiencing more 
emergency department utilizations.  The reason for this suggestion is based on the 
nature of the administrative data used in this study.  Emergency department utilizations 
are categorized as outpatient services.  Although the cost of emergency services are 
accounted for by the data, the actual type of outpatient service utilized is limited by not 
being able to determine emergency services and is an area for further investigation. 
The findings from this study could be limited by an averaging effect.  While 
focusing on between-patient outcomes, the effects of intra-individual differences are 
minimized with the assumption that all individuals follow a similar pattern.  Within-
person differences likely exist in this population given the proportion of the individuals 
who were near death.  Specifically, terminal decline, or the decrements in individuals’ 
functional capacities that span the time from months to years before death, has intra-
individual variation that is a within-person process (Gerstorf & Ram, 2013).  However, 
these differences become masked in between-person analyses, such as those 
conducted in this study.  However, some of the within-person variation is accounted for 
in the later analyses that controlled for time to death since time to death can serve as a 
proxy for unnamed mortality-related casual processes (Gerstorf & Ram, 2013). 
Additionally, program variation is likely and should be examined in relation to 
service use and cost (Olsan et al.).  Program leaders have suggested that variation in 
the duration and intensity of services exist across programs.  Some programs operate 
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on a shorter-term acute basis, where others implement the program as long-term and 
continuous.  Additionally, program leaders have suggested that future work should 
examine differences in outcomes based on the programs that focus on primary care 
versus those that implement an interdisciplinary care approach.   
In terms of intensity, the average VHA HBPC caseloads are between 20 to 30 
patients to each registered nurse (or licensed practical nurse), 80 to 105 per social 
worker, 85 to 155 per rehabilitation therapist, and 95 to 125 per dietician.  Given these 
high caseloads, future research would be behooved to examine whether the size of the 
caseloads effect outcomes.  Perhaps more staffing results in better care and improved 
outcomes such as preventing avoidable service use (e.g., hospitalizations) and lowering 
expenditures. Increased staffing levels have been associated with positive outcomes in 
other studies, for example, in acute care hospitals (Kane, Shamliyan, Mueller, Duval, & 
Wilt, 2007), nursing homes (Konetzka, Stearns, & Park, 2008), and in assisted living 
facilities (Stearns et al., 2007).  In this study, an intent-to-treat design was utilized in that 
service intensity (referred to as a proxy for staffing) was not a requirement in order to 
determine the effects of the program on the outcomes. 
Although this study refined the matching algorithm and inclusion criteria to an 
extent, other areas for future research include further refinement to the matching 
method and should consider other frailty indices, alternative matching techniques, and 
further restriction of the matching caliper. It would be advantageous if measures related 
functional limitations, cognition, and the availability of caregiver assistance were 
available for matching in future studies. 
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The inability to control for patient frailty is a limitation of this study.  Other studies 
examining the effect of VHA HBPC found that those with the highest frailty scores had 
lower costs suggesting that this group has the greatest potential for savings (De Jonge 
et al., 2014).  Although further investigation into frailty indices may be warranted, others 
have suggested that diagnoses using ICD-9-CM codes, as was done in this study, 
compared to the use of measures of functionality, were better predictors of mortality 
among a frail population (Levy et al., 2015).   
Another limitation of this study is that propensity scores are generated from 
observed covariates, therefore, if there are associations between unobserved factors 
and probability of treatment, these are not accounted for and such residual differences 
could exist.  Additionally, there is inherent subjectivity in deciding which propensity 
score method to use (e.g., matching, adjustment, inverse weighting).  Since the 
propensity score approach involved two models, if either model is incorrect, biased 
estimates of the causal effect are possible (Vittinghoff et al., 2012).   
Other limitations include the dichotomized nature of the service eligibility variable.  
A more nuanced approach to examining service eligibility could provide a better 
understanding of the effect of VHA HBPC compared to how different levels of service 
eligibility effect service use.  A notable limitation is the lack of Medicare data.  A 
complete picture of the effect of VHA HBPC would be provided by merging Medicare 
files with VA files.  However, this study was restricted to VA data.  The presence of 
advance directives was not accounted for which could affect service use.  Finally, 
measures of quality of care were not accounted for in this study due to the nature of the 
data.  
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Strengths of the study include the use of population-based, longitudinal VHA data, 
and the study design which addressed statistical challenges including selection bias and 
yielded relatively well-matched comparison cohorts to draw conclusions regarding the 
effect of VHA HBPC. Ethical considerations limit the ability to conduct randomized 
controlled trials to determine the effect of any healthcare delivery models.  Thus, this 
study used matched comparison groups to understand the effect of VHA HBPC on 
service utilization, cost, and survival.   
 
Policy Recommendations 
 Several policy recommendations can be made based on the findings from this 
study.  First, more research should be supported in order to better understand the 
effectiveness of VHA HBPC.  First, program variation is likely and understanding how 
programs different and how such a differences effect outcomes would be advantageous 
to the program’s longevity.  Additionally, research support should be provided to gain a 
better understanding into the effects of VHA HBPC recipients who receive palliative 
care.  The research from this study suggests that VHA HBPC recipients receiving 
palliative care could possibly be an effective subgroup to target for optimal outcomes.  
These findings are not surprising given past research suggesting that participating in 
palliative care following hospitalization can have a beneficial effect on service use, cost, 
and satisfaction with care (Brumley, Enguidanos, & Cherin, 2003; Gade et al., 2008). 
Understanding how palliative care and VHA HBPC work in conjunction to produce 
positive outcomes is warranted.   
 Another policy recommendation is to develop a method to identify an appropriate 
group of VHA HBPC participants that would benefit from palliative care.  Given the 
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findings from this research and others, palliative care can have a multitude of beneficial 
effects.  It would be justified to provide clinical guidance in terms of identifying patients 
in VHA HBPC who could benefit from such services.  A checklist could be implemented 
such as the ones developed by The Center to Advance Palliative Care’s Consensus 
Panel which developed two checklists to screen patients for unmet palliative care needs 
(Weissman & Meier, 2011).  Palliative care services can be provided in conjunction with 
restorative care.  Therefore, this recommendation is not specific to end-of-life care. 
 To address end of life, it is recommended that training in end-of-life care be 
provided for the clinicians and staff of VHA HBPC.  Given the high rate of death of 
program participants, it is likely that end-of-life issues arise frequently whether they be 
related to clinical care or psychosocial issues.  Therefore, specialized, continuous end-
of-life care trainings for all those involved with VHA HBPC patient-care should be 
provided. 
 The final policy recommendation is to develop clinical guidelines and/or best 
practices for which VHA HBPC programs can utilize.  This patient population is 
vulnerable and complex and providing care in one’s home likely presents situations that 
clinic-setting professionals do not confront.  Therefore, in order to optimize the 
effectiveness of the program, guidelines should be provided to clinicians serving 
patients in VHA HBPC.  Additionally, these guidelines should be updated as research 
on the program evolves. 
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Conclusions 
Past research found that, among a sample of VHA patients, interactions with the 
health-care system and with providers were major concerns and presented significant 
obstacles to self-care (Noel, Frueh, Larme, & Pugh, 2005).  For those that have 
significant difficulty with getting to the clinic to receive care, VHA HBPC provides an 
option to alleviate access barriers such as transportation, mobility, and the general 
difficulty in navigating the system by bringing services into the patient’s home. Some 
have even gone as far as to suggest that advances in medicine and technology allow 
complex care to be delivered to certain patients in their homes and is comparable to 
being treated in the hospital (Boling et al., 2013).  While this study did not address the 
comparability of hospital care to home care, the results of this study – at least in terms 
of those in the program for six or more months and palliative care recipients - 
underscore the idea that successful home-based programs, such as VHA HBPC, should 
be maintained to address the unmet needs of patients and Veterans who need care 
provided in the home, albeit the need for further examination on program effectiveness. 
Although this study did not find lower expenditures as a result of VHA HBPC 
participation, reduced nursing home use and hospitalization can be expected after six 
months of program participation.  Though not captured in this study, patient and 
caregiver satisfaction have been reported elsewhere (Beck, Arizmendi, Purnell, Fultz, & 
Callahan, 2009; Cummings et al., 1990; Edes et al., 2014; Hughes et al., 2000) and as 
others have suggested, favorable outcomes are not always correlated with high patient 
satisfaction (Kennedy, Tevis, & Kent, 2014).  Factors outside of desired outcomes seem 
to influence patient satisfaction and this appears to be the case for those in VHA HBPC. 
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Although VHA HBPC only serves a fraction of the VHA patient population, 
recipients of VHA HBPC are a vulnerable population who have multiple chronic 
conditions that are often characterized as costly and account for a disproportionate level 
of resource utilization, as evidenced through this study.  However, this does not mean 
that the program is not effective in meeting the needs of these patients or doesn’t assist 
in keeping patients independent for longer than otherwise expected, although the 
findings here cannot speak to this effect.  A modest impact on resource use with little to 
no impact on expenditures has been reported in other programs that attempt to manage 
patients with complex, chronic conditions in the community (Agency for Healthcare 
Research and Quality, 2013a; Peikes, Chen, Schore, & Brown, 2009; Weinberger, 
Oddone, & Henderson, 1996).  Like these, this study should not undermine the value of 
the program to the patient, but should be used to improve care by providing insight as to 
where improvement and research efforts should focus. 
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